AMENDED AND RESTATED STOCK PURCHASE AGREEMENT
EXHIBIT 10(b)
AMENDED AND RESTATED STOCK PURCHASE AGREEMENT
BY AND BETWEEN
AVISEP, S.A. DE C.V.,
BEVISEP, S.A. DE C.V.,
AND
THE XXXXXXX-XXXXXXXX COMPANY,
XXXXXXX-XXXXXXXX (CARIBBEAN) N.V.
DATED SEPTEMBER 16, 2013
TABLE OF CONTENTS
Article I DEFINITIONS | 2 | ||||
Section 1.1 | Definitions | 2 | |||
Section 1.2 | Construction | 16 | |||
Section 1.3 | Annexes, Exhibits and the Disclosure Letter | 18 | |||
Section 1.4 | Knowledge | 18 | |||
Article II SALE OF SHARES | 19 | ||||
Section 2.1 | Sale of Shares | 19 | |||
Section 2.2 | Purchase Price; Delivery of Funds and other payments | 19 | |||
Section 2.3 | Final Purchase Price | 20 | |||
Section 2.4 | Closing; Closing Deliverables | 23 | |||
Article III REPRESENTATIONS AND WARRANTIES OF SELLERS | 25 | ||||
Section 3.1 | Organization | 25 | |||
Section 3.2 | Authorization; Non-contravention | 25 | |||
Section 3.3 | Ownership of Shares | 26 | |||
Section 3.4 | The Subject Companies | 27 | |||
Section 3.5 | Capitalization of the Company | 27 | |||
Section 3.6 | Capitalization of the Company’s Subsidiaries | 28 | |||
Section 3.7 | Consents and Approvals | 29 | |||
Section 3.8 | Financial Statements; Undisclosed Liabilities | 29 | |||
Section 3.9 | Compliance with Laws; Permits | 30 | |||
Section 3.10 | Litigation | 31 | |||
Section 3.11 | Tax Matters | 31 | |||
Section 3.12 | Personal Property | 33 | |||
Section 3.13 | Intellectual Property | 33 | |||
Section 3.14 | Insurance | 34 | |||
Section 3.15 | Employee Benefits and Labor Relations | 34 | |||
Section 3.16 | Transactions with Related Parties | 37 | |||
Section 3.17 | Company Contracts | 37 | |||
Section 3.18 | Real Properties; Real Property Leases | 39 | |||
Section 3.19 | Bank Accounts | 40 | |||
Section 3.20 | Environmental Matters | 40 | |||
Section 3.21 | Brokers | 41 |
i
TABLE OF CONTENTS
(continued)
Section 3.22 | Inventory | 41 | |||
Section 3.23 | Proceedings | 41 | |||
Section 3.24 | Product Liability | 42 | |||
Section 3.25 | No Additional Representations | 42 | |||
Article IV REPRESENTATIONS AND WARRANTIES OF PURCHASERS | 43 | ||||
Section 4.1 | Due Organization, Good Standing and Corporate Power of Purchasers | 43 | |||
Section 4.2 | Authorization; Non-contravention | 43 | |||
Section 4.3 | Consents and Approvals | 44 | |||
Section 4.4 | Broker’s or Finder’s Fee | 44 | |||
Section 4.5 | Financing | 44 | |||
Section 4.6 | Solvency | 44 | |||
Section 4.7 | Proceedings | 45 | |||
Section 4.8 | Experienced Investor | 45 | |||
Section 4.9 | Investigation by Purchasers | 45 | |||
Section 4.10 | Exclusivity of Representations | 46 | |||
Article V COVENANTS | 46 | ||||
Section 5.1 | Access to Information Concerning Properties and Records | 46 | |||
Section 5.2 | Confidentiality | 47 | |||
Section 5.3 | Conduct of the Business of the Subject Companies Pending the Closing Date | 48 | |||
Section 5.4 | Exclusive Dealing | 50 | |||
Section 5.5 | Commercially Reasonable Efforts; Consents | 51 | |||
Section 5.6 | Public Announcements | 51 | |||
Section 5.7 | Notification of Certain Matters | 51 | |||
Section 5.8 | Supplements to Schedules | 52 | |||
Section 5.9 | Antitrust Laws | 52 | |||
Section 5.10 | Preservation of Records | 53 | |||
Section 5.11 | Employee Benefits | 54 | |||
Section 5.12 | Non-Competition; Non-Interference | 55 | |||
Section 5.13 | Non-Solicitation of Employees | 56 | |||
Section 5.14 | Release | 56 | |||
Section 5.15 | Transaction Expenses | 56 | |||
Section 5.16 | Environmental Investigations | 57 | |||
ii
TABLE OF CONTENTS
(continued)
Article VI CONDITIONS PRECEDENT | 58 | ||||
Section 6.1 | Conditions to the Obligations of Each Party | 58 | |||
Section 6.2 | Conditions to the Obligations of Purchasers | 58 | |||
Section 6.3 | Conditions to the Obligations of Sellers | 59 | |||
Section 6.4 | Frustration of Closing Conditions | 60 | |||
Article VII TERMINATION AND ABANDONMENT | 60 | ||||
Section 7.1 | Termination | 60 | |||
Section 7.2 | Effect of Termination | 62 | |||
Article VIII INDEMNIFICATION | 62 | ||||
Section 8.1 | Survival of Representations and Warranties | 62 | |||
Section 8.2 | Indemnification by Sellers | 62 | |||
Section 8.3 | Indemnification by Purchasers | 63 | |||
Section 8.4 | Limitation on Indemnification | 63 | |||
Section 8.5 | Losses Net of Insurance, etc. | 64 | |||
Section 8.6 | Indemnification Procedure | 68 | |||
Section 8.7 | Third-Party Claims | 69 | |||
Section 8.8 | Sole Remedy/Waiver | 70 | |||
Section 8.9 | Release of the Indemnification Escrow Fund | 70 | |||
Article IX TAX MATTERS | 71 | ||||
Section 9.1 | Section 338 Election | 71 | |||
Section 9.2 | Tax Returns Due After the Closing Date | 73 | |||
Section 9.3 | Tax Refunds | 75 | |||
Section 9.4 | Cooperation on Tax Matters | 75 | |||
Section 9.5 | Amended Returns and Retroactive Elections | 76 | |||
Section 9.6 | Certain Transfer Taxes and Fees | 76 | |||
Article X MISCELLANEOUS | 76 | ||||
Section 10.1 | Fees and Expenses | 76 | |||
Section 10.2 | Extension; Waiver | 76 |
iii
TABLE OF CONTENTS
(continued)
Section 10.3 | Notices | 77 | |||
Section 10.4 | Entire Agreement | 78 | |||
Section 10.5 | Binding Effect; Benefit; Assignment | 78 | |||
Section 10.6 | Amendment and Modification | 78 | |||
Section 10.7 | Counterparts | 78 | |||
Section 10.8 | Applicable Law | 78 | |||
Section 10.9 | Arbitration | 78 | |||
Section 10.10 | Severability | 79 | |||
Section 10.11 | Specific Enforcement | 79 | |||
Section 10.12 | Rules of Construction | 79 | |||
ANNEXES, EXHIBITS AND SCHEDULES | |||||
Annex A - Shares | |||||
Annex B - Phase II Facilities | |||||
Exhibit A - [ Intentionally Deleted ] | |||||
Exhibit B - Sellers Allocation | |||||
Exhibit C - Form of Release | |||||
Exhibit D - Form of Stock Purchase Agreement |
iv
AMENDED AND RESTATED STOCK PURCHASE AGREEMENT
This AMENDED AND RESTATED STOCK PURCHASE AGREEMENT (this “Agreement”) dated September 16, 2013 is executed by and among (i) on one side as sellers (A) Avisep, S.A. de C.V. a company organized under the laws of Mexico (the “Primary Seller”), and (B) Bevisep, S.A. de C.V. a company organized under the laws of Mexico (each a “Seller” and, collectively, “Sellers”); and (ii) on the other side as purchasers (A) The Xxxxxxx-Xxxxxxxx Company, a corporation incorporated under the laws of the State of Ohio, U.S. (“Primary Purchaser”), and (B) Xxxxxxx-Xxxxxxxx (Caribbean) N.V., a corporation incorporated under the laws of Curacao (each a “Purchaser” and, collectively, “Purchasers” and, together with the Sellers, the “Parties”).
WITNESSETH:
WHEREAS, the Parties entered into that certain Stock Purchase Agreement, dated November 9, 2012, as amended pursuant to that certain Amendment No. 1 to Stock Purchase Agreement dated June 24, 2013, and further amended pursuant to that certain Amendment No. 2 to Stock Purchase Agreement dated August 21, 2013, pursuant to which the Sellers agreed to sell and the Purchasers agreed to purchase all of the issued and outstanding shares representing the capital stock of Consorcio Comex, S.A. de C.V. and Conaxe, S.A. de C.V.;
WHEREAS, the transaction contemplated herein has received the appropriate clearance, consent, waiver and/or approval from the Antitrust Authorities in the U.S. and Canada, as well as from the Mexican Foreign Investment Authority;
WHEREAS, Primary Seller and Primary Purchaser continue to seek the appropriate clearance, consent, waiver and/or approval from the Antitrust Authority in Mexico and expect to receive such clearance, consent, waiver and/or approval at a future date;
WHEREAS, the Parties desire to provide for and complete the sale and purchase of Consorcio Comex, S.A. de C.V.'s business in the U.S. and Canada held through Comex USA, Inc (“Comex USA”) pursuant to the terms set forth in the stock purchase agreement (the “Comex USA Stock Purchase Agreement”) attached hereto as Exhibit D, which Comex USA Stock Purchase Agreement will be executed by the parties thereto concurrently with the execution of this Agreement;
WHEREAS, Sellers own the shares in Consorcio Comex, S.A. de C.V. (the “Company”) and Conaxe, S. A. de C. V. (“Conaxe”) as described in Annex A hereto (the “Shares”), which Shares collectively represent all of the issued and outstanding shares of capital stock of the Company and Conaxe;
1
WHEREAS, Sellers desire to sell, and Purchasers desire to purchase, the Shares pursuant to the terms and subject to the conditions set forth in this Agreement and in the proportions indicated in Annex A hereto;
WHEREAS, upon consummation of the purchase and sale of the Shares pursuant to this Agreement, Purchasers shall own all of the outstanding shares of capital stock of the Company and Conaxe: and
WHEREAS, the Parties desire to amend and restate this Agreement pursuant to the terms set forth herein;
NOW, THEREFORE, in consideration of the premises and of the mutual covenants, representations, warranties and agreements herein contained, the Parties, intending to be legally bound, agree as follows:
Article I
DEFINITIONS
Section 1.1 Definitions. Defined terms in this Agreement and in the Annexes, Exhibits and Schedules to this Agreement, which may be identified by the capitalization of the first letter of each principal word thereof, have the meanings assigned to them below. Other terms may be defined elsewhere in the text of this Agreement and, unless otherwise indicated, shall have such meaning throughout this Agreement.
“Accounting Principles” means the accounting principles, policies, practices and methods described in Section 1.1(a) of the Sellers Disclosure Letter.
“Affiliate” of any Person shall mean any other Person directly or indirectly controlling, controlled by, or under common control with, such Person; provided, that, for the purposes of this definition and this Agreement, “control” (including, with correlative meanings, the terms “controlled by” and “under common control with”), as used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by Contract or otherwise.
“Agreed Claims” has the meaning ascribed to such term in Section 8.6(c).
“Alternate Transaction” has the meaning ascribed to such term in Section 5.4.
“Antitrust Authorities” means (i) in Mexico, the Federal Antitrust Commission (Comisión Federal de Competencia); (ii) in the U.S., the Federal Trade Commission, the Antitrust Division of the United States Department of Justice and the
2
attorneys general of the several states of the United States; (iii) in Canada, the Competition Bureau; and (iv) any other Governmental Entity in the jurisdictions referred to above and any other jurisdiction, with authority over the transactions contemplated hereby pursuant to applicable Antitrust Laws.
“Antitrust Filings” has the meaning ascribed to such term in Section 5.9(a)(i).
“Antitrust Laws” means (i) in Mexico the Federal Antitrust Law (Ley Federal de Competencia Económica) and its regulations, as amended, as well as any other applicable Laws and Orders in Mexico; (ii) in the U.S. (A) the Xxxxxxx Act, as amended, (B) the Xxxxxxx Act, as amended, (C) the HSR Act, and (D) the Federal Trade Commission Act, as amended, as well as any other applicable Laws and Orders in the U.S.; (iii) in Canada, the Competition Act, as well as any other applicable Laws and Orders in Canada; and (iv) all other Laws and Orders that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade or otherwise governing antitrust matters applicable to the Sellers, the Purchasers or the transactions contemplated by this Agreement.
“Audited Financial Statements” has the meaning ascribed to such term in Section 3.8(a)(i).
“Balance Sheet Date” has the meaning ascribed to such term in Section 3.8(a)(i).
“Business Day” means any day except a Saturday, a Sunday or any other day on which commercial banks are required or authorized to close in Mexico City, Mexico, or New York, New York, U.S.
“Cash and Cash Equivalents” means cash and cash equivalents, determined in accordance with NIF.
“Claim Certificate” has the meaning ascribed to such term in Section 8.6(a).
“Closing” has the meaning ascribed to such term in Section 2.4(a).
“Closing Balance Sheet” has the meaning ascribed to such term in Section 2.3(b).
“Closing Cash” means the Cash and Cash Equivalents of the Company and the Company’s Subsidiaries on a consolidated basis calculated in accordance with NIF as of 11:59 P.M. on the Business Day immediately prior to the Closing Date.
3
“Closing Date” has the meaning ascribed to such term in Section 2.4(a).
“Closing Funded Indebtedness” has the meaning ascribed to such term in Section 2.3(b).
“Closing Working Capital” means the Consolidated Current Assets of the Company and the Company’s Subsidiaries on a consolidated basis less the Consolidated Current Liabilities of the Company and the Company’s Subsidiaries on a consolidated basis as determined in accordance with the Accounting Principles as of 11:59 P.M. on the Business Day immediately prior to the Closing Date.
“Closing Payment” has the meaning ascribed to such term in Section 2.2(b).
“Closing Statement” has the meaning ascribed to such term in Section 2.3(b).
“Code” means the Internal Revenue Code of 1986 of the U.S., as amended and the Treasury Regulations thereunder.
“Collateral Source” has the meaning ascribed to such term in Section 8.5(a)(iv).
“Comex USA Stock Purchase Agreement” has the meaning set forth in the Recitals.
“Company” has the meaning ascribed to such term in the Recitals.
“Company Contracts” has the meaning ascribed to such term in Section 3.17(a).
“Company Employees” has the meaning ascribed to such term in Section 5.11(a).
“Company Intellectual Property” means any Intellectual Property that is owned by any of the Subject Companies.
“Company Permit” has the meaning ascribed to such term in Section 3.9(b).
“Company Personal Property” has the meaning ascribed to such term in Section 3.12.
“Company’s Subsidiaries” means all of the Company’s direct or indirect Subsidiaries (but excluding Comex USA and its Subsidiaries).
4
“Company Transaction Expenses” means all expenses of Sellers and the Subject Companies incurred or to be incurred (prior to and through the Closing Date) in connection with the negotiation, preparation and execution of this Agreement and the consummation of the transactions contemplated hereby and the Closing, including fees and disbursements of attorneys, accountants, brokers, financial and other advisors and service providers, travel and entertainment expenses, and meeting and presentation expenses, payable by any Seller or Subject Company.
“Competing Business” has the meaning ascribed to such term in Section 5.12(i).
“Conaxe” has the meaning ascribed to such term in the Recitals.
“Confidential Material” means all information (written or oral) that is confidential or proprietary to any of the Subject Companies regarding the Subject Companies. The term “Confidential Material” shall not include (i) information that is or becomes generally available to the public, other than as a result of disclosure by Sellers, the Subject Companies or their respective Affiliates and Representatives in violation of this Agreement; and (ii) becomes available to Sellers or their Representatives from a Person other than the other Seller or any Subject Company on a non-confidential basis; provided that such Person was not known by Sellers or their respective Representatives to be bound by a confidentiality agreement with, or other contractual, legal or fiduciary obligation of confidentiality to, any of the Subject Companies or their Representatives with respect to such materials.
“Confidentiality Agreement” has the meaning ascribed to such term in Section 5.2(a).
“Consolidated Current Assets” means, without duplication, the line items set forth under the heading “Current Assets” described in Section 1.1(b) of the Sellers Disclosure Letter, as determined in accordance with NIF.
“Consolidated Current Liabilities” means, without duplication, the line items set forth under the heading “Current Liabilities” described in Section 1.1(b) of the Sellers Disclosure Letter, as determined in accordance with NIF.
“Contract” means any written agreement, understanding, arrangement, contract, commitment, letter of intent, purchase order, note, bond, mortgage, indenture, guarantee, license, franchise, consent, or other instrument or obligation and any amendments thereto.
“Corrective Actions” has the meaning ascribed to such term in Section 8.5(b)(iii).
5
“Deductible” has the meaning ascribed to such term in Section 8.4(a)(i).
“Disputed Amounts” has the meaning ascribed to such term in Section 2.3(d).
“Due Diligence Materials” has the meaning ascribed to such term in Section 4.9(i)(A).
“End Date” has the meaning ascribed to such term in Section 7.1(ii)(B).
“Environment” means the air (including indoor air), surface water or ground water (including navigable waters, marine waters, drinking water, streams, ponds, drainage basins and water bodies), any land, all living organisms, sediment, soil or subsurface strata, natural or mineral resources and the environment or living environment.
“Environmental Approvals” has the meaning ascribed to such term in Section 3.20(a)(ii).
“Environmental Law” means any Law, Order or other requirement of Law relating to (i) the pollution or the protection of the Environment, including air emissions, water discharges, soil remediation, natural or mineral resources or any other regulation standing for the conservation, protection, contamination or remediation of the Environment, or (ii) the handling, storage, generation, treatment, disposal or human exposure to, or the Release of, Hazardous Substance, or (iii) safety or health (with respect to Hazardous Substances), as well as any Law that relates to:
(a)advising appropriate authorities, employees, and the public of intended or actual Release of Hazardous Substances, violations of discharge limits, or other prohibitions and of the commencements of activities, such as resource extraction or construction, that could have an impact on the Environment;
(b)preventing or reducing to acceptable levels the Release of Hazardous Substances into the Environment;
(c)reducing the quantities, preventing the Release, or minimizing the hazardous characteristics of wastes that are generated;
(d)assuring that products are designed, formulated, packaged, and used so that they do not present unreasonable risks to human health (with respect to Hazardous Substances) or the Environment when used or disposed of;
(e)protecting resources, species, or ecological amenities;
6
(f)reducing to acceptable levels the risks inherent in the transportation of Hazardous Substances;
(g)cleaning up pollutants that have been Released, preventing the threat of Release, or paying the costs of such clean up or prevention; or
(h)making responsible parties pay private parties, or groups of them, for damages done to their health or the Environment, or permitting self-appointed representatives of the public interest to recover for injuries done to public assets.
“Environmental Liabilities” means, without duplication, any Losses resulting from, arising out of or relating to (i) non-compliance by any Subject Company with Environmental Laws prior to the Closing Date; (ii) obligations of Purchasers or any Subject Company to carry out Corrective Actions, provided, however, that such Corrective Actions (A) are required to be performed pursuant to the Environmental Laws or a final or immediately enforceable Order by a Governmental Entity or (B) are necessary to eliminate, reduce or otherwise remedy an immediate danger to the Environment as reasonably determined by the Purchasers concerning circumstances or events occurring prior to the Closing Date; or (iii) Environmental Matters involving or related to a Subject Company occurring prior to the Closing Date.
“Environmental Matters” means (i) the storage, placement, release, threat of release, spillage, deposit, escape, disposal, leak, emission or presence of Hazardous Substances in the Environment, including damages to natural resources; (ii) the creation of noise, vibration, radiation, common law or statutory nuisance; or (iii) other matters relating to the protection of workplace safety (with respect to Hazardous Substances) or the Environment arising out of the manufacturing, processing, treatment, storage, handling, use, possession, purchase, sale, import, export or transportation of Hazardous Substances.
“ERISA” has the meaning ascribed to such term in Section 3.15(a).
“ERISA Affiliate” has the meaning ascribed to such term in Section 3.15(a).
“Escrow” means the escrow account created pursuant to the Escrow Agreement.
“Escrow Agreement” shall mean the escrow agreement to be entered into on the closing of the transaction contemplated under the Comex USA Stock Purchase Agreement, as amended to reflect the transaction contemplated under this Agreement.
7
“Escrow Amount” means the Indemnification Escrow Amount plus the Purchase Price Escrow Amount plus the Golden Parachute Escrow Amount plus the Remedy Escrow Amount.
“Exchange Act” means the Securities Exchange Act of 1934 of the U.S., as amended, and the rules and regulations promulgated thereunder.
“Exchange Rate” has the meaning ascribed to such term in Section 2.3(e).
“Expert” has the meaning ascribed to such term in Section 2.3(d)(i).
“Final Purchase Price” has the meaning ascribed to such term in Section 2.3(a).
“Financial Statements” has the meaning ascribed to such term in Section 3.8(a).
“Foreign Investment Approval” means the authorization by Foreign Investment Authority pursuant to Article 9 of the Foreign Investment Law of Mexico (Ley de Inversión Extranjera).
“Foreign Investment Authority” means the National Commission of Foreign Investments (Comisión Nacional de Inversiones Extranjeras) of Mexico.
“Funded Indebtedness” of any Person means, without duplication, (i) indebtedness for borrowed money or indebtedness issued or incurred in substitution or exchange for indebtedness for borrowed money; (ii) indebtedness evidenced by any note, bond, debenture, or other debt instrument or debt security; (iii) any accrued and unpaid interest owing by such Person with respect to any indebtedness of a type described in clauses (i) and (ii); and (iv) any prepayment penalties, commissions and/or fees and associated Taxes; provided, that Funded Indebtedness shall not include accounts payable to trade creditors, accrued expenses arising in the Ordinary Course of Business consistent with past practice, the endorsement of negotiable instruments for collection in the Ordinary Course of Business, and Funded Indebtedness owing from any wholly owned Subject Company to any other wholly owned Subject Company.
“GAAP” means (i) in respect of Mexico, NIF; and (ii) in respect of any other jurisdictions, the generally accepted accounting principles applicable in the relevant jurisdiction, in both cases, as effective from time to time.
“Golden Parachute Escrow Amount” means an amount equivalent to the Golden Parachute Obligations, which amount is to be deposited by Primary Purchaser with the escrow agent pursuant to the Escrow Agreement for a period of twenty four months
8
commencing on the Closing Date, and held and released pursuant to the terms and subject to the conditions set forth in this Agreement and the Escrow Agreement.
“Golden Parachute Escrow Fund” means the escrow fund established pursuant to the Escrow Agreement in respect of the Golden Parachute Escrow Amount and the golden parachute escrow amount deposited with the escrow agent pursuant to the Comex USA Stock Purchase Agreement.
“Golden Parachute Obligations” means the aggregate dollar amount, which any of the Subject Companies would be obligated to pay pursuant to all of the agreements entered into with each of the individuals identified in Section 1.1(c) of the Sellers Disclosure Letter (each such Person, a “Recipient”), determined as if such obligations were triggered on the last day of the month prior to the Closing Date.
“Governmental Entity” means any federal, state, municipal, provincial or local court, arbitral tribunal, administrative agency, department, board, instrumentality or commission or other governmental or regulatory agency or authority or any securities exchange, of Mexico, the U.S., Canada or any other any jurisdiction.
“Hazardous Substance” means any and all minerals, metals, materials, chemicals, waste or other substance that is listed, defined, designated, or classified as, or otherwise determined to be, hazardous, radioactive, or toxic or a pollutant or a contaminant under or pursuant to any Law, Order or requirement of Law applicable to the Subject Companies’ business, including petroleum and all derivatives thereof and asbestos or asbestos-containing materials.
“HSR Act” means the Xxxx-Xxxxx-Xxxxxx Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder.
“ICC Rules” has the meaning ascribed to such term in Section 10.9(a).
“IMSS” means the Mexican Institute of Social Security (Instituto Mexicano del Seguro Social).
“Income Tax” means any federal, state, local or non-U.S. income tax measured by or imposed on net income, including any interest, penalty, or addition thereto, whether disputed or not.
“Income Tax Return” means any annual return, declaration, report, claim for refund, or information return or statement relating to Income Taxes, including any schedule or attachment thereto.
“Indemnification Escrow Amount” means $85,034,000, which amount is to be deposited by Primary Purchaser with the escrow agent pursuant to the Escrow
9
Agreement, and held and released pursuant to the terms and subject to the conditions set forth in this Agreement and the Escrow Agreement. The Indemnification Escrow Amount may be increased as set forth in Section 5.16.
“Indemnification Escrow Fund” means the escrow fund established pursuant to the Escrow Agreement in respect of the Indemnification Escrow Amount and the indemnification escrow amount deposited with the escrow agent pursuant to the Stock Purchase Agreement.
“Indemnified Party” has the meaning ascribed to such term in Section 8.6(a).
“Indemnifying Party” has the meaning ascribed to such term in Section 8.6(a).
“Independent Valuation Expert” shall mean Xxxx XxXxxxxx, or such other independent valuation expert who is mutually agreed upon by the Parties.
“Intellectual Property” means all intellectual property in any jurisdiction, whether owned or held for use under license, whether registered or unregistered, including such rights in and to: (i) issued patents and all provisional and pending patent applications, any and all divisions, continuations, continuations-in-part, reissues, continuing patent applications, reexaminations, and extensions thereof, any counterparts claiming priority therefrom, utility models, patents of importation/confirmation, certificates of invention, and certificates of registration (collectively, “Patents”), (ii) registered or unregistered copyrights and copyrightable works, including databases (or other collections of information, data, works or other materials), packaging artwork and design rights (collectively, “Copyrights”), (iii) Trade Secrets, (iv) computer software (including source code and object code, data files, application programming interfaces, computerized databases and other software-related specifications (collectively, “Software”)), (v) registered and unregistered trademarks, trade names, service marks and service names, brand names, trade dress, logos and certification marks, in each case including all registrations, applications, recordings, renewals and extensions and common law rights relating to any of the foregoing and the goodwill associated with any of the foregoing (“Trademarks”), (vi) Internet domain names, (vii) rights of publicity and other rights to use the names and likeness of individuals, and (viii) claims, causes of action and defenses relating to any of the foregoing; in each case, including registrations, applications, recordings and extensions and common law rights relating to any of the foregoing.
“Insurance Policies” has the meaning ascribed to such term in Section 3.14(a).
“IP Licenses” has the meaning ascribed to such term in Section 3.17(a)(v).
10
“IRS” has the meaning ascribed to such term in Section 3.15(a)(ii).
“Law” means any statute, law, ordinance, policy, rule, code, regulation, order, or decree of any Governmental Entity and all judicial interpretations thereof.
“Leased Real Property” means the real properties leased under the Real Property Leases.
“Liabilities” means any and all debts, liabilities and obligations, whether accrued or fixed, known or unknown, absolute or contingent, matured or unmatured or determined or determinable.
“Liens” means any liens, pledges, collateral, security interests, easements, mortgages, charges, rights of way, encroachments, gratuitous bailments, options, conditional sales (other than sales in the Ordinary Course of Business) or other types of title retention arrangements, deed of trust, reversion, restrictive covenant, condition or restriction of any kind, including any restriction on the use, voting, transfer, receipt of income or other exercise of any attributes of ownership, or other encumbrances.
“Loss” or “Losses” means, without duplication: (i) any and all claims, actions, causes of action, judgments, awards, settlements, Liabilities, direct losses (xxxxx) and direct damages (perjuicios) but excluding consequential, punitive and exemplary damages; provided, however, that in the case of consequential, punitive and exemplary damages, to the extent that any such damages are actually paid by an Indemnified Party hereunder as a Third Party Claim, then any such damages so paid shall be considered direct damages; (ii) fines, penalties, costs or damages, including reasonable fees and expenses of attorneys; and (iii) all costs and expenses related to Corrective Actions.
“Material Adverse Effect” means any change, effect, event, occurrence, state of facts or development that (A) is or would reasonably be expected to be materially adverse to the business, assets, properties, results of operations or condition (financial or otherwise) of the Subject Companies, taken as a whole; provided, however, that (i) changes in economic or political conditions or the financing, banking, currency or capital markets in general; (ii) changes in Laws or changes in accounting requirements or principles; (iii) changes affecting industries, markets or geographical areas in which the Subject Companies conduct their respective businesses; (iv) the negotiation, announcement, execution, pendency or performance of this Agreement or the consummation of the transactions contemplated by this Agreement, (v) conduct by the Company or any of the Company Subsidiaries prohibited under this Agreement for which any Purchaser gave its prior written consent; (vi) any natural disaster or any acts of terrorism, sabotage, military action, armed hostilities or war (whether or not declared) or any escalation or worsening thereof, whether or not occurring or commenced before or after the date of this Agreement; or (vii) any action required to be taken under any Law or Order, in the case of each such matter described in
11
the foregoing clauses (i) through (vii) shall be deemed not to constitute a “Material Adverse Effect” and shall not be considered in determining whether a “Material Adverse Effect” has occurred except with respect to clauses (i), (ii), (iii) and (v), to the extent that such changes are disproportionately adverse to the business, assets, properties, results of operations or condition, (financial or otherwise) of the Subject Companies taken as a whole as compared to other companies in the industries in which the Subject Companies operate; (B) prevents or materially impairs or delays the ability of the Sellers to perform their obligations under this Agreement or would be reasonably expected to do so; or (C) results in material damages to, or the destruction of, more than 50% (fifty per cent) of the manufacturing capacity at the manufacturing facilities of Empresas Aga or Tepexpan, that are not remedied on or before the Closing Date, then such damage or destruction shall constitute a “Material Adverse Effect”. For the avoidance of doubt, a “Material Adverse Effect” shall be measured only against past performance of the Company and the Company Subsidiaries.
“Mexico” means the United Mexican States.
“NIF” means the Mexican Financial Information Norms (Normas de Información Financiera), as in effect from time to time, issued by the Mexican Board of Financial Information (Consejo Mexicano de Normas de Información Financiera).
“Non-U.S. Employee Benefit Plans” has the meaning ascribed to such term in Section 3.15(b).
“Notice of Objection” has the meaning ascribed to such term in Section 2.3(c).
“Order” means any judgment, order, injunction, decree, writ, permit or license of any Governmental Entity.
“Ordinary Course of Business” means with respect to any Person, the operation of its business in a manner that is consistent with the past recurring operations and/or practices of such Person.
“Permit” means any approvals, authorizations, consents, licenses, concessions, permits or certificates of a Governmental Entity.
“Permitted Liens” means (i) mechanics’, carriers’, workmen’s, repairmen’s or other like Liens arising in the Ordinary Course of Business securing amounts that are not past due; (ii) leases, subleases and similar agreements including those set forth in Section 3.18(b) of the Sellers Disclosure Letter; (iii) Liens for Taxes not yet due and payable or for current Taxes that may thereafter be paid without penalty or which are being contested in good faith and by appropriate proceedings and for which reserves have been established in the Financial Statements when so required pursuant to GAAP; (iv) Liens affecting the real property set forth on Section 3.18 of the Sellers Disclosure Letter; (v) Liens created by non-
12
exclusive licenses granted in the Ordinary Course of Business in any Intellectual Property; and (vi) any Liens in favor of Purchasers created by the actions of Purchasers of any of their Affiliates over the Shares and/or the business.
“Person” means and includes an individual, a partnership, a limited partnership, a limited liability partnership, a joint venture, a corporation, a limited liability company, an association, a trust, an unincorporated organization, a group, a Governmental Entity and any other legal entity.
“Present Fair Salable Value” has the meaning ascribed to such term in Section 4.6.
“Primary Parties” means, collectively, Primary Purchaser and Primary Seller.
“Primary Purchaser” has the meaning ascribed to such term in the Preamble.
“Primary Seller” has the meaning ascribed to such term in the Preamble.
“Proceeding” has the meaning ascribed to such term in Section 3.10.
“Property Taxes” has the meaning ascribed to such term in Section 9.2(b)(i).
“Purchase Price” has the meaning ascribed to such term in Section 2.2(a).
“Purchase Price Adjustment” has the meaning ascribed to such term in Section 2.3(e).
“Purchase Price Escrow Amount” means $18,500,000, which amount is to be deposited by Purchasers with the escrow agent pursuant to the Escrow Agreement, and held and released pursuant to the terms and subject to the conditions set forth in this Agreement and the Escrow Agreement.
“Purchase Price Escrow Fund” means the escrow fund established pursuant to the Escrow Agreement in respect of the Purchase Price Escrow Amount.
“Purchaser” has the meaning ascribed to such term in the Preamble.
“Purchaser Indemnitees” has the meaning ascribed to such term in Section 8.2.
“Purchasers’ Proposed Calculations” has the meaning ascribed to such term in Section 2.3(b).
13
“Real Property Leases” has the meaning ascribed to such term in Section 3.18(b)(ii).
“Related Party Transactions” means any Contracts of any kind between any of the Subject Companies, on the one hand, and any officer, shareholders, employee or director of any of the Subject Companies or any Affiliate thereof, on the other hand.
“Related Person” has the meaning ascribed to such term in Section 5.14(a).
“Release” means disposing, discharging, injecting, spilling, leaking, leaching, dumping, emitting, escaping, emptying and seeping into or upon any land or water or air or otherwise entering into the Environment.
“Released Parties” has the meaning ascribed to such term in Section 5.14(a).
“Remedy” means any action required of Purchasers, their Subsidiaries and/or their Affiliates by the Antitrust Authorities in Mexico in order to obtain approval of the transaction contemplated by this Agreement by the Antitrust Authorities in Mexico including, but not limited to, any requirement, condition, limitation, contract or Order to: (i) sell, license, assign, transfer, divest, hold separate, or otherwise dispose of any assets, business (or portion thereof) of Purchasers, Purchasers' Subsidiaries or Affiliates, or of Company, Company's Subsidiaries or Affiliates; (ii) conduct, restrict, operate, provide services, invest or otherwise change the assets, business (or portion thereof) of Purchasers, Purchasers' Subsidiaries or Affiliates, or of Company, Company's Subsidiaries or Affiliates, in any manner; or (iii) impose any restriction, requirement or limitation on the operation of the business (or portion thereof) of Purchasers, Purchasers' Subsidiaries or Affiliates, or of Company, Company's Subsidiaries or Affiliates.
“Remedy Contribution” shall have the meaning set forth in Section 8.5(f).
“Remedy Escrow Fund” means the Remedy Escrow Amount, which amount is to be deposited by Purchasers with the escrow agent pursuant to the Escrow Agreement, and held and released pursuant to the terms and subject to the conditions set forth in this Agreement and the Escrow Agreement.
“Remedy Escrow Amount” means $40,000,000.
“Remedy Impact” shall have the meaning set forth in Section 8.5(f).
“Representatives” of any Person means such Person’s directors, managers, officers, agents, attorneys, consultants, advisors or other Persons acting on behalf of such Person.
14
“SAR” means the Law of Systems of Savings for the Retirement (Ley de los Sistemas de Ahorro para el Retiro).
“Seller” has the meaning ascribed to such term in the Preamble.
“Seller-Related Persons” has the meaning ascribed to such term in Section 8.5(d).
“Sellers Disclosure Letter” has the meaning ascribed to such term in the first paragraph of Article III.
“Seller Indemnitees” has the meaning ascribed to such term in Section 8.3.
“September 2012 Balance Sheet” has the meaning ascribed to such term in Section 3.8(a).
“Shares” has the meaning set forth in the Recitals.
“Short Period” has the meaning ascribed to such term in Section 9.2(a).
“Short Period Return” has the meaning ascribed to such term in Section 9.2(a).
“Signing Funded Indebtedness” means the amount of $465,595,000, calculated as described in Section 1.1(d) of the Sellers Disclosure Letter.
“Solvent” has the meaning ascribed to such term in Section 4.6.
“Straddle Period” has the meaning ascribed to such term in Section 9.2(b).
“Subject Companies” means, collectively, the Company and Conaxe together with all of the Company’s Subsidiaries, which are listed in Section 1.1(e) of the Sellers Disclosure Letter (but excluding Comex USA and its Subsidiaries).
“Subsidiary”, with respect to any Person, means (i) any entity more than fifty percent (50%) of the equity or stock of any class or classes of which having by the terms thereof ordinary voting power to elect a majority of the directors of such corporation is owned by such Person directly or indirectly through one or more Subsidiaries of such Person; and (ii) any partnership, association, joint venture, limited liability company or other entity in which such Person directly or indirectly through one or more Subsidiaries of such Person has more than a fifty percent (50%) equity interest.
“Target Working Capital” means the amount of $118,208,532 calculated as described in Section 1.1(b) of the Sellers Disclosure Letter.
15
“Taxes” means all taxes, assessments, charges, duties, fees, levies or other governmental charges including all federal, state, local, foreign and other income, franchise, profits, gross receipts, capital gains, capital stock, transfer, sales, import, use, value added, occupation, property, excise, severance, stamp, license, payroll, social security, withholding and other taxes, including in Mexico any payments due under any social security Laws including those related to the Mexican Social Security Institute (Instituto Mexicano del Seguro Social), the National Institute for Workers’ Housing (Instituto del Fondo Nacional de la Vivienda para los Trabajadores) and the Retirement Savings System (Sistema de Ahorro para el Retiro), as well as any assessments, charges, duties, compensatory quotas, countervailing duties, fees, levies or other governmental charges of any kind whatsoever (whether payable directly or by withholding and whether or not requiring the filing of a Return), all estimated taxes, deficiency assessments, additions to tax, penalties, updates (actualizaciones) and interest thereon.
“Tax Return” means all returns, statements, forms and reports for Taxes that are required to be filed under applicable Law.
“Third Party Claim” has the meaning ascribed to such term in Section 8.7(a).
“Trade Secrets” means, collectively, any trade secrets and other confidential information, including ideas, formulas, compositions, inventions (whether patentable or unpatentable and whether or not reduced to practice), know-how, manufacturing and production processes and techniques, molds, research and development information, drawings, specifications, designs, plans, proposals, technical data, copyrightable works, financial and marketing plans and customer and supplier lists and information.
“Update Schedule” has the meaning ascribed to such term in Section 5.8.
“U.S.” or “United States” means the United States of America or any political subdivision thereof.
“U.S. Employee Benefit Plans” has the meaning ascribed to such term in Section 3.15.
“U.S. Multiemployer Plan” has the meaning ascribed to such term in Section 3.15(a)(i).
“Working Capital Adjustment” has the meaning ascribed to such term in Section 2.3(b).
Section 1.2 Construction.
In this Agreement, unless the context otherwise requires:
16
(i)words expressed in the singular number shall include the plural and vice versa; words expressed in the masculine shall include the feminine and neuter gender and vice versa;
(ii)references to Articles, Sections, Exhibits, Annexes, Sections of the Sellers Disclosure Letter, the Preamble and Recitals are references to articles, sections, exhibits, annexes, disclosure schedules, the preamble and recitals of this Agreement, and the descriptive headings of the several Articles and Sections of this Agreement and the Sellers Disclosure Letter (as applicable) are inserted for convenience only, do not constitute a part of this Agreement and shall not affect in any way the meaning or interpretation of this Agreement;
(iii)whenever this Agreement refers to a number of days, that number shall refer to calendar days unless Business Days are specified and whenever any action must be taken under this Agreement on or by a day that is not a Business Day, then that action may be validly taken on the next day that is a Business Day;
(iv)the words “hereof”, “herein”, “hereto” and “hereunder”, and words of similar import, shall refer to this Agreement as a whole and not to any provision of this Agreement;
(v)this “Agreement” or any other agreement or document shall be construed as a reference to this Agreement or, as the case may be, such other agreement or document as the same may have been, or may from time to time be, amended or supplemented;
(vi)“include”, “includes”, and “including” are deemed to be followed by the words “without limitation” whether or not they are in fact followed by such words or words of similar import;
(vii)the word “extent” in the phrase “to the extent” shall mean the degree to which a subject or thing extends, and such phrase shall not mean simply “if”;
(viii)references to “Dollars”, “dollars” or “$”, without more are to the lawful currency of the United States of America;
(ix)references to “Pesos”, “pesos” or “Ps$”, without more are to the lawful currency of Mexico;
(x)references to NIF or GAAP in this Agreement shall be understood and construed as NIF or GAAP as the case may be, applied on a basis consistent with the Financial Statements and the Accounting Principles; provided however that,
17
solely with respect to the calculation of the Consolidated Current Assets, Consolidated Current Liabilities, Working Capital Adjustment, the Closing Funded Indebtedness, the Closing Cash, the Closing Balance Sheet, the Closing Statement, the Purchasers’ Proposed Calculations, the Notice of Objection, the Disputed Amounts and the Expert’s resolution of the Disputed Amounts and the Purchase Price Adjustment, in the event of any conflict between the Accounting Principles and GAAP or NIF, as the case may be, the Accounting Principles shall control;
(xi)for purposes of the calculations set forth in this Agreement, to the extent any of the Subject Companies’ accounting is kept in Pesos or any Loss may be materialized in Pesos, the calculation of any of the thresholds set forth in Dollars in this Agreement shall be made using the Exchange Rate (as defined below) published on November 9, 2012 (or if no Exchange Rate is published on November 9, 2012, the last Exchange Rate published prior to November 9, 2012);
(xii)references to the Primary Seller shall be construed as to the Primary Seller acting on behalf and for the benefit of Sellers, in the capacity of Primary Seller as agent (comisionista mercantil) of Bevisep, S.A. de C.V., pursuant to an in accordance with Article 273 of the Commerce Code (Código de Comercio) and therefore, Bevisep, S.A. de C.V., hereby approves, ratifies and confirms any and all acts performed by Primary Seller on its behalf pursuant to and in connection with this Agreement and the Escrow Agreement;
(xiii)to the extent that a representation or warranty of Sellers contained in Article III of this Agreement addresses a particular issue with specificity, and no breach by Sellers exists under such specific representation or warranty, Sellers shall not be deemed to be in breach of any other representation or warranty (with respect to such issue) that addresses such issue with less specificity than the specific representation or warranty; and
(xiv) references to “as of the date hereof”, “as of the date of this Agreement”, “the date of this Agreement”, and words of similar import, shall be construed to mean as of both November 9, 2012 and as of the date of this Agreement.
Section 1.3 Annexes, Exhibits and the Disclosure Letter. The Annexes, Exhibits and the Sellers Disclosure Letter are incorporated into and form an integral part of this Agreement.
Section 1.4 Knowledge. When any representation, warranty, covenant or agreement contained in this Agreement is expressly qualified by reference to (i) the “Knowledge of Sellers” or words of similar import, it shall mean the knowledge of the individuals set forth in Section 1.4(a) of the Sellers Disclosure Letter after due and reasonable
18
inquiry; and (ii) the “Knowledge of Purchasers” or words of similar import, it shall mean the knowledge of the individuals set forth in Section 1.4(b) of the Sellers Disclosure Letter after due and reasonable inquiry.
Article II
SALE OF SHARES
Section 2.1 Sale of Shares. On the terms, and subject to the satisfaction of the Conditions Precedent (condiciones suspensivas) set forth in Article VI of this Agreement, Sellers hereby agree to sell to Purchasers, and Purchasers (either directly or through a previously identified Affiliate of Purchasers and previously approved by Sellers, which approval shall not be unreasonably withheld) hereby agree to purchase from Sellers, at the Closing the Shares, free and clear of all Liens and together with all accrued rights and benefits thereto. At the Closing, Sellers shall endorse “in property” (endoso en propiedad) the stock certificates representing the Shares in favor of Purchasers. Additionally, Sellers shall take such action as is necessary and legally required to reflect the sale, assignment, transfer, endorsement and delivery of the Shares, free and clear of all Liens, on the books and records of the Company.
Section 2.2 Purchase Price; Delivery of Funds and other payments.
(a) On the terms and subject to the conditions of this Agreement, Sellers agree to sell to Purchasers, and Purchasers agree to purchase from Sellers, the Shares, free and clear of any Liens, for a purchase price of $1,782,321,132 (the “Purchase Price”). The Purchase Price is subject to adjustment pursuant to Section 2.3.
(b) At the Closing, Purchasers shall pay to Sellers an amount equal to (i) $1,638,787,132 less (ii) the Golden Parachute Obligations as a partial payment of the Purchase Price (the “Closing Payment”). The Closing Payment shall be made by wire transfer of immediately available funds to an account designated by each of the Sellers in writing to Purchasers at least three (3) Business Days prior to the Closing. The Closing Payment and any Purchase Price Adjustment shall be allocated among Sellers (with respect to their Shares in the Company) as set forth on Exhibit B.
(c) On or before the Closing Date, Sellers shall pay any and all Company Transaction Expenses.
(d) At the Closing, Purchasers shall deliver to the escrow agent of the Escrow Agreement the Escrow Amount by wire transfer of immediately available funds.
19
(e) On the Closing Date, the Purchasers, on the name and behalf of the Company, may be required to pay to the holders of the Closing Funded Indebtedness an amount sufficient to repay all such Closing Funded Indebtedness.
Section 2.3 Final Purchase Price.
(a) The Purchase Price shall be adjusted and finally determined upwards or downwards (the “Final Purchase Price”), by (i) subtracting or adding, if any, the Working Capital Adjustment, (ii) subtracting or adding, as the case may be, the difference between the Closing Funded Indebtedness and the Signing Funded Indebtedness, and (iii) adding the Closing Cash.
(b) Promptly after the Closing Date, and in any event not later than sixty (60) days following the Closing Date, Primary Purchaser shall prepare and deliver to Primary Seller (i) an unaudited consolidated balance sheet of the Company and the Company’s Subsidiaries as of 11:59 P.M. on the Business Day immediately prior to the Closing Date prepared in accordance with NIF (the “Closing Balance Sheet”); and (ii) a statement (the “Closing Statement”) setting forth Purchasers’ good faith calculations (the “Purchasers’ Proposed Calculations”) of (A) the amount of the Closing Cash; (B) the Closing Working Capital; (C) the amount, if any, by which the Target Working Capital differs from the Closing Working Capital (the “Working Capital Adjustment”); (D) the Funded Indebtedness of the Company as of 11:59 P.M. on the Business Day immediately prior to the Closing Date (the “Closing Funded Indebtedness”); (E) the difference between the Closing Funded Indebtedness and the Signing Funded Indebtedness; and (F) a calculation of the Final Purchase Price based on such amounts. Purchasers’ Proposed Calculations shall be made in accordance with NIF. Purchasers shall cause the Subject Companies and their personnel to provide Primary Seller with prompt and reasonable access to the Subject Companies’ auditors and accounting and other personnel and to the books and records of the Subject Companies and any other document or information reasonably requested by Primary Seller (including the workpapers of the Subject Companies’ auditors) in order to allow Primary Seller to review the Purchasers’ Proposed Calculations.
(c) In the event that Primary Seller does not object to the Closing Balance Sheet or Purchasers’ Proposed Calculations by written notice of objection (the “Notice of Objection”) delivered to Primary Purchaser within forty-five (45) days after Primary Seller’s receipt of the Closing Balance Sheet and Purchasers’ Proposed Calculations, the calculation of the Final Purchase Price pursuant to Purchasers’ Proposed Calculations shall be deemed final and binding. A Notice of Objection under this Section 2.3(c) shall set forth in reasonable detail Primary Seller’s alternative calculations, if any, of (i) the amount of the Closing Cash; (ii) the Closing Working Capital and the Working Capital Adjustment calculated by reference thereto; (iii) the Closing Funded Indebtedness; and (iv) a calculation of the Final Purchase Price based on such amounts.
20
(d) If Primary Seller delivers a Notice of Objection to Primary Purchaser within the forty-five (45) day period referred to in Section 2.3(c), then any element of Purchasers’ Proposed Calculations that is not in dispute on the date such Notice of Objection is given shall be treated as final and binding and any dispute (all such amounts, the “Disputed Amounts”) shall be resolved as set forth in this Section 2.3(d):
(i) the Primary Parties shall promptly endeavor in good faith to resolve the Disputed Amounts listed in the Notice of Objection. If a written agreement determining the Disputed Amounts has not been reached within ten (10) Business Days after the date of receipt by Primary Purchaser from Primary Seller of the Notice of Objection, the resolution of such Disputed Amounts shall be submitted to any partner of KPMG Xxxxxxxx Xxxxx, S.C., different than the partners that are currently in charge of the external audit of the financial information of the Company (the “Expert”), which the Primary Parties hereby jointly and irrevocably appoint;
(ii) the Primary Parties shall use their commercially reasonable efforts to cause the Expert to render a decision in accordance with this Section 2.3(d) within thirty (30) days of the submission of the Disputed Amounts, to the Expert. For the purposes hereof, upon submission of the Disputed Amounts to the Expert, the Primary Parties shall provide to the Expert all documents that each of them deems necessary, including a statement of reasons explaining their corresponding position. Such documents shall be delivered no later than fifteen (15) days following submission for Expert’s intervention. Within ten (10) days following the receipt of such documents, the Expert may request the Primary Parties to provide further information, in the understanding that such additional information shall only be requested for clarifying purposes. During such term, the Expert may, set up meetings with the Primary Parties as the Expert may deem reasonably necessary;
(iii) the determination made by the Expert shall be final and binding upon each Party hereto in terms of article 2252 of the Federal Civil Code (Código Civil Federal); accordingly, the Final Purchase Price shall be recalculated based upon the final determination of the Expert with respect to the Disputed Amounts and the Final Purchase Price, as so recalculated, shall be deemed to be final and binding;
(iv) if the Primary Parties submit any Disputed Amounts to the Expert for resolution, Sellers and Purchasers shall each pay their own costs and expenses incurred under this Section 2.3(d). Sellers shall be responsible for that fraction of the fees and costs of the Expert where (A) the numerator is the absolute value of the difference between Primary Seller’s aggregate position with respect to the Final Purchase Price and the Final Purchase Price as recalculated based upon Expert’s final determination with respect to the Disputed Amounts; and (B) the denominator
21
is the absolute value of the difference between Primary Seller’s aggregate position with respect to the Final Purchase Price and Primary Purchaser’s aggregate position with respect to the Final Purchase Price, and Purchasers shall be responsible for the remainder of such fees and costs; and
(v) the Primary Parties shall use their commercially reasonable efforts to cause the Expert’s determination of the Disputed Amounts to be no less than the lesser of the amount claimed by either Primary Seller or Primary Purchaser, and no greater than the greater of the amount claimed by either Primary Seller or Primary Purchaser; provided that, if, notwithstanding the commercially reasonable efforts of Primary Seller or Primary Purchaser, (i) the Expert’s determination of any Disputed Amount is less than the lesser of the amounts claimed by either Primary Seller or Primary Purchaser, then such disputed amount shall be deemed to be the lesser of the amounts claimed by either Primary Seller or Primary Purchaser or (ii) the Expert’s determination of any Disputed Amount is more than the greater of the amounts claimed by either Primary Seller or Primary Purchaser, then such disputed amount shall be deemed to be the greater of the amounts claimed by either Primary Seller or Primary Purchaser.
(e) Upon the determination, in accordance with Sections 2.3(c) or Section 2.3(d) hereof, of the Final Purchase Price, Primary Seller (on behalf of Sellers) or Primary Purchaser (on behalf of Purchasers), as the case may be, shall make the payment required by this Section 2.3(e). The amount payable by Sellers or Purchasers pursuant to this Section 2.3(e) is referred to herein as the “Purchase Price Adjustment” and shall be treated as an adjustment to the Purchase Price for federal, state, local and foreign income Tax purposes. For purposes of the calculations set forth herein, to the extent any of the Subject Companies’ accounting is kept in Pesos and therefore the calculations set forth herein are made in Pesos, any Purchase Price Adjustment shall be converted into Dollars using the Exchange Rate to satisfy obligations denominated in foreign currency payable in Mexico (Tipo de cambio para solventar obligaciones denominadas en moneda extranjera) published in the Federal Official Gazette (Diario Oficial de la Federación) by the Mexican Central Bank (Banco de México) (the “Exchange Rate”) on the Closing Date (or if no Exchange Rate is published on the Closing Date, the last Exchange Rate published prior to the Closing Date). Accordingly:
(i) if the Final Purchase Price is greater than the Purchase Price, then within three (3) Business Days after the determination of the Final Purchase Price: (a) the Primary Parties shall cause the escrow agent to immediately release to Primary Seller on behalf of Sellers the Purchase Price Escrow Fund in full; and (b) Primary Purchaser shall, on behalf of Purchasers, pay to Primary Seller on behalf of Sellers, an amount equal to the difference between the Purchase Price and the Final Purchase Price. Any amount to be paid by Primary Purchaser on behalf of Purchasers pursuant
22
to this Section 2.3(e)(i) shall be paid by wire transfer of immediately available funds to one or more accounts designated by Primary Seller on behalf of Sellers in writing to Primary Purchaser promptly after the final determination of the Final Purchase Price; and
(ii) if the Final Purchase Price is less than the Purchase Price, then within three (3) Business Days after the determination of the Final Purchase Price, the Primary Parties shall cause the escrow agent to immediately release from the Purchase Price Escrow Fund: (a) to Primary Purchaser on behalf of Purchasers, an amount equal to the difference between the Purchase Price and the Final Purchase Price; and (b) to Primary Seller on behalf of Sellers, the balance, if any, of the Purchase Price Escrow Fund. In the event that the amount of funds in the Purchase Price Escrow Fund is less than the Purchase Price Adjustment, then Primary Seller on behalf Sellers shall pay or cause to be paid to Primary Purchaser on behalf of Purchasers such difference. Any amount to be paid by Primary Seller on behalf of Sellers pursuant to this Section 2.3(e)(ii) shall be paid by wire transfer of immediately available funds to an account designated by Primary Purchaser in writing to Primary Seller promptly after the final determination of the Final Purchase Price.
Section 2.4 Closing; Closing Deliverables.
(a) Subject to the satisfaction or waiver of all of the conditions set forth in Article VI, the sale referred to in Section 2.1 hereof (the “Closing”) shall take place in Xxxxxx Xxxx, Xxxxxxx Xxxxxxxx, Xxxxxx, at 10:00 A.M. at the offices of White & Case, S.C., within three (3) Business Days, after the last of the conditions set forth in Article VI is satisfied or waived (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the fulfillment or waiver of those conditions), or at such other time, date or place as the Primary Parties shall agree in writing. Such date is herein referred to as the “Closing Date”.
(b) At the Closing, Primary Seller shall deliver or cause to be delivered to Primary Purchaser:
(i) certificates representing the Shares, duly endorsed in property (endoso en propiedad) by each of the respective Sellers;
(ii) a certified copy of the share ledger of the Company reflecting: (A) the shareholding structure of the Company on the Closing Date immediately before the transfer of the Shares; (B) the transfer of the Shares; and (C) the shareholding structure of the Company on the Closing Date immediately after the transfer of the Shares to Purchasers;
23
(iii) a certificate signed by Sellers, dated as of the Closing Date, confirming the matters set forth in Section 6.2(i) and Section 6.2(ii);
(iv) counterparts to the Escrow Agreement, duly executed by Sellers and the escrow agent;
(v) resignations of the members of the board of directors and statutory auditor (comisario) of the Company and all Company Subsidiaries;
(vi) copies of all consents and waivers referred to in Section 3.2 hereof;
(vii) executed and fully effective and valid releases in a form attached hereto as Exhibit C from the Affiliates of Sellers set forth in Section 2.4(b) of the Sellers Disclosure Letter; and
(viii) evidence reasonably satisfactory to Purchasers that the shares of capital stock identified in Section 2.4(b)(viii) of the Sellers Disclosure Letter have been transferred to Conaxe.
(c) At the Closing, Primary Purchaser shall deliver to Primary Seller:
(i) evidence of payment by wire transfer of immediately available funds of the Closing Payment;
(ii) upon receipt of the original duly endorsed certificates representing the Shares, a certification evidencing such receipt;
(iii) a certificate signed by an authorized officer of each Purchaser, dated as of the Closing Date, confirming the matters set forth in Section 6.3(i) and Section 6.3(ii) hereof;
(iv) a counterpart to the Escrow Agreement, duly executed by the Purchasers; and
(v) a counterpart to the minutes of the shareholders’ meeting of each of the Subject Companies, granting in favor of each director or sole administrator and statutory auditors or equivalents, the broadest release permitted by Law in respect of their legal performance of their duties and obligations as directors and statutory auditors, as applicable; (B) the revocation of the powers of attorney as agreed upon between Sellers and Purchasers; and (C) the appointment of new members of the board of directors and new statutory auditors.
24
Article III
REPRESENTATIONS AND WARRANTIES OF SELLERS
Concurrent with the execution of this Agreement, certain parties hereto along with related parties are entering into the Comex USA Stock Purchase Agreement. Accordingly, for the avoidance of doubt, Sellers make no representations and warranties with respect to Comex USA or its Subsidiaries in this Article III.
Concurrent with the execution of the original stock purchase agreement on November 9, 2012, the Sellers delivered to Primary Purchaser a certain disclosure letter setting forth exceptions and disclosures to the representations and warranties made by the Sellers. For purposes of this Agreement, such disclosure letter has been restated by Sellers, as of September 16, 2013, to reflect the sale of Comex USA, Inc. on September 16, 2013 pursuant to the Comex USA Stock Purchase Agreement. Except as set forth in the restated disclosure letter, dated as of November 9, 2012, delivered by Sellers to Primary Purchaser (the “Sellers Disclosure Letter”) concurrently with the execution of this Agreement (it being agreed that any matter disclosed pursuant to any Section of the Sellers Disclosure Letter shall be deemed disclosed for purposes of any other Section of the Sellers Disclosure Letter to the extent the applicability of the disclosure to such other Section is reasonably apparent on the face of such disclosure), each Seller severally and not jointly represents and warrants to Purchasers as of November 9, 2012 and as of the Closing as follows:
Section 3.1 Organization.
Each Seller is a company duly organized and existing under the laws of Mexico.
Section 3.2 Authorization; Non-contravention.
(a) Such Seller has the requisite power and authority and has taken all action necessary to execute and deliver this Agreement, the Escrow Agreement and all other instruments and agreements to be delivered by such Seller as contemplated hereby and thereby, to perform its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. The execution, delivery and performance by such Seller of this Agreement, the Escrow Agreement and all other instruments and agreements to be delivered by such Seller as contemplated hereby and thereby, the consummation by such Seller of the transactions contemplated hereby and thereby and the performance of its obligations hereunder and thereunder have been and, in the case of documents required to be delivered at Closing, will be, duly authorized and approved. This Agreement and the Escrow Agreement have been, and all other instruments and agreements to be executed and delivered by such Seller as contemplated hereby and thereby will be,
25
duly executed and delivered by such Seller. Assuming that this Agreement and the Escrow Agreement constitute legal, valid and binding obligations of each other party hereto, this Agreement and the Escrow Agreement constitute legal, valid and binding obligations of such Seller enforceable against such Seller in accordance with their terms, except as such enforcement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar Laws affecting the enforcement of creditors’ rights generally. Assuming that all other instruments and agreements to be delivered by such Seller as contemplated hereby and thereby constitute legal, valid and binding obligations of each other party hereto, such instruments and agreements will constitute legal, valid and binding obligations of such Seller enforceable against such Seller in accordance with their terms, except as such enforcement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar Laws affecting the enforcement of creditors’ rights generally.
(b) The execution of this Agreement and all other instruments and agreements to be delivered by such Seller as contemplated hereby do not, and the consummation of the transactions contemplated hereby and thereby will not, except, in the case of clauses (ii)-(iv) below, to the extent that would not be material to the Subject Companies (i) conflict with any of the provisions of the articles of incorporation, bylaws, trust agreement or other equivalent charter documents of such Seller or any of the Subject Companies; (ii) create any Lien (other than Permitted Liens) upon any of the properties or assets of such Seller or the Subject Companies; (iii) conflict with or result in a breach of, or constitute a default under, or, other than as provided in Section 3.2(b) of the Sellers Disclosure Letter, result in the acceleration of any obligation or loss of any benefits under, any Company Contract, Company Permit or other instrument to which such Seller or any of the Subject Companies is a party or by which any of its property or asset are bound; or (iv) subject to (A) the applicable Antitrust Laws and (B) receipt of the consents, approvals, authorizations, declarations, filings and notices referred to in Section 3.2(b) of the Sellers Disclosure Letter, contravene any Law or any Order applicable to such Seller, any Subject Company or by which any properties or assets of such Seller or any Subject Company are bound.
Section 3.3 Ownership of Shares. Such Seller has good and valid title to the Shares set forth opposite such Seller’s name in Section 3.3 of the Sellers Disclosure Letter free and clear of all Liens, and is the record and beneficial owner thereof. Such Shares were acquired by such Seller in compliance with applicable Law. Other than this Agreement, there is no outstanding Contract with any Person for such Person to purchase, redeem or otherwise acquire any outstanding shares of the capital stock of any of the Subject Companies. At the Closing, such Seller will convey good and valid title to such Shares, free and clear of all Liens, Orders, Contracts or other limitations whatsoever.
26
Section 3.4 The Subject Companies.
(a) The Subject Companies are companies duly incorporated, validly existing and in good standing under the Laws of the jurisdiction in which they were incorporated and have the requisite corporate power and authority and all necessary Permits to own, lease and operate their properties and to carry on their businesses as now being conducted. Each Subject Company is duly qualified or licensed to do business, and is in good standing, in each jurisdiction where the character of the properties owned, leased or operated by it or the nature of its business makes such qualification, licensing or good standing necessary, except for such failures to be so qualified, licensed or in good standing that are not material to such Subject Company not qualified, licensed or in good standing.
(b) Except as provided in Section 3.4(b) of the Sellers Disclosure Letter, there are no restrictions of any kind that prevent or restrict the payment of dividends or other distributions by any of the Subject Companies other than those imposed by the Laws of general applicability of their respective jurisdictions of organization.
(c) Except for the outstanding dividends and capital reimbursements as provided in Section 3.4(c) of the Sellers Disclosure Letter, there are no dividends payable by any of the Subject Companies or contributions for future capital increases in favor of any of the Subject Companies.
Section 3.5 Capitalization of the Company. The authorized capital stock of the Company is set forth in Section 3.5(a) of the Sellers Disclosure Letter hereto and conforms to the information entered into the Company’s stock register and capital variations register. The Shares constitute all the issued and outstanding equity interests of the Company and are represented by stock certificates validly issued by the Company. The Shares have been duly authorized and validly issued and subscribed and are fully paid and are non-assessable, and are not subject to, and were not issued in violation of any preemptive rights or other similar rights. Except for the Shares, no shares of capital stock or other equity interests of the Company are issued, reserved for issuance or outstanding. None of the Company nor any Seller is a party to any outstanding or authorized option, warrant, right (including any preemptive right), subscription, claim of any character, agreement, obligation, convertible or exchangeable securities, or other commitments contingent or otherwise, relating to the capital stock or other equity or voting interests in the Company, pursuant to which a Seller or the Company is or may become obligated to issue, deliver or sell or cause to be issued, delivered or sold, shares of capital stock of or other equity or voting interests in, the Company or any securities convertible into, exchangeable for, or evidencing the right to subscribe for or acquire, any shares of the capital stock of or other equity or voting interests in the Company. There are no outstanding or authorized (i) stock appreciation, phantom stock, profit participation or similar rights with respect to the capital stock of, or other equity or voting interests in the Company, (ii) dividends payable by the Company or (iii) bonds, debentures,
27
notes or other indebtedness the holders of which have the right to vote (or convertible into, exchangeable for, or evidencing the right to subscribe for or acquire securities having the right to vote) with the stockholders of the Company on any matter, other than those set forth in Section 3.5 of the Sellers Disclosure Letter. There are no irrevocable proxies and no voting agreements with respect to any capital stock of, or other equity or voting interests in, the Company.
Section 3.6 Capitalization of the Company’s Subsidiaries.
(a) The authorized capital stock and owners of each of the Company’s Subsidiaries is set forth in Section 3.6(a) of the Sellers Disclosure Letter hereto and conforms to the information entered into each such Subsidiary’s stock register and capital variations register. The shares set forth in Section 3.6(a) of the Sellers Disclosure Letter constitute all the issued and outstanding equity interests of each of the Company’s Subsidiaries and are represented by stock certificates validly issued by each such Subsidiary. Such shares have been duly authorized and validly issued and subscribed and are fully paid and non-assessable, and are not subject to, and were not issued in violation of any preemptive rights or other similar rights. The Company or one or more of the Company’s Subsidiaries is the record and beneficial holder of all or the majority of the issued and outstanding equity interests of the Company’s Subsidiaries as set forth on Section 3.6(a) of the Sellers Disclosure Letter, free and clear of all Liens. No shares of capital stock or other equity interests of each of the Company’s Subsidiaries are issued, reserved for issuance or outstanding. None of the Company, such Seller nor any of the Company’s Subsidiaries are a party to any outstanding or authorized option, warrant, right (including any preemptive right), subscription, claim of any character, agreement, obligation, convertible or exchangeable securities, or other commitments contingent or otherwise, relating to the capital stock or other equity or voting interests in the Company’s Subsidiaries, pursuant to which any of the Company, such Seller or any of the Company’s Subsidiaries is or may become obligated to issue, deliver or sell or cause to be issued, delivered or sold, shares of capital stock of or other equity or voting interests in, any of the Company’s Subsidiaries or any securities convertible into, exchangeable for, or evidencing the right to subscribe for or acquire, any shares of the capital stock of or other equity or voting interests in any of the Company’s Subsidiaries.
(b) There are no outstanding or authorized stock appreciation, phantom stock, profit participation or similar rights with respect to the capital stock of, or other equity or voting interests in, any of the Company’s Subsidiaries. None of the Company’s Subsidiaries have any authorized or outstanding bonds, debentures, notes or other indebtedness the holders of which have the right to vote (or convertible into, exchangeable for, or evidencing the right to subscribe for or acquire securities having the right to vote) with the stockholders of any of the Company’s Subsidiaries on any matter. There are no irrevocable proxies and no voting agreements with respect to any capital stock of, or other equity or voting interests in, any of the Company’s Subsidiaries. Section 3.6(b) of the Sellers
28
Disclosure Letter sets forth all shares or other equity interests that are owned by the Company or the Subject Companies that are not Subsidiaries and all such shares or other equity interests are owned by them free and clear of any and all Liens.
Section 3.7 Consents and Approvals. Assuming all required Antitrust Filings are made and clearances and/or approvals thereunder received, and the Foreign Investment Approval is obtained, and that any and all filings, authorizations and other consents applicable to the Purchasers are made and obtained, no consent of or filing with any Governmental Entity or any other Person, must be obtained or made in connection with the execution and delivery of this Agreement by such Seller or the consummation by such Seller of the transactions contemplated by this Agreement, except for those set out in Section 3.7 of the Sellers Disclosure Letter.
Section 3.8 Financial Statements; Undisclosed Liabilities.
(a) The Company has furnished Purchasers with (i) the audited consolidated balance sheet of the Company and the Company’s Subsidiaries as of December 31, 2011 (the “Balance Sheet Date”), December 31, 2010 and December 31, 2009, the related audited consolidated statements of income, stockholders’ equity and cash flows, retained earnings and changes in financial position for the fiscal years ended December 31, 2011, December 31, 2010 and December 31, 2009 (collectively, the “Audited Financial Statements”); and (ii) the interim unaudited consolidated balance sheet of the Company and the Company’s Subsidiaries as of September 30, 2012 (the “September 2012 Balance Sheet”), and the related interim unaudited consolidated statements of income, stockholders’ equity and cash flows, retained earnings and changes in financial position for the nine (9) months then ended. The consolidated financial statements referred to above, including the footnotes thereto (collectively, the “Financial Statements”), except as described therein, and in the case of the September 2012 Balance Sheet, except for the absence of notes thereto and subject to normal year-end audit adjustments, have been prepared in accordance with NIF.
(b) The Audited Financial Statements fairly present, in all material respects and unless otherwise specified therein, the consolidated financial position of the Company and the Company’s Subsidiaries, taken as a whole, as of the Balance Sheet Date, December 31, 2010 and December 31, 2009, respectively, and the related consolidated statements of income, stockholders’ equity and cash flows fairly present, in all material respects, the consolidated results of operations, stockholders’ equity and cash flows of the Company and the Company’s Subsidiaries, taken as a whole, for the fiscal years then ended unless otherwise specified therein. The September 2012 Balance Sheet of the Company and the Company’s Subsidiaries and the related interim unaudited consolidated statement of income fairly present, in all material respects, the financial position of the Company and the Company’s Subsidiaries, taken as a whole, as of the date thereof and the related
29
consolidated statement of income fairly presents, in all material respects, the results of the operations of the Company and the Company’s Subsidiaries, taken as a whole, for the period indicated.
(c) Except as set forth in Section 3.8(c) of the Sellers Disclosure Letter, the Subject Companies have no Liabilities that are not already reflected in the Financial Statements in compliance with NIF, except for Liabilities incurred in the Ordinary Course of Business.
(d) Since the Balance Sheet Date, no event has occurred which has resulted in, or is likely to result in, a Material Adverse Effect.
Section 3.9 Compliance with Laws; Permits.
(a)The Subject Companies have conducted their respective businesses in compliance in all material respects with all applicable Laws, and have not received written notice of any material violation or non-compliance thereof.
(b)Except as set forth in Section 3.9(b) of the Sellers Disclosure Letter, (i) each of the Subject Companies owns or possesses, and is in compliance with all material Permits which are necessary to lawfully enable it to carry on its business and to own, lease, use or operate its assets and properties (each, a “Company Permit”), free and clear of any Liens (other than Permitted Liens); (ii) all of such Company Permits are valid, binding and in full force and effect; (iii) the Subject Companies have not received any written notice or claim from any Governmental Entity or other Person that asserts, or raises the possibility of assertion of, any noncompliance with any Company Permit and, no condition or state of facts exists that would provide a basis for any such assertion; and (iv) no loss, revocation, withdrawal, suspension, cancellation, termination of, or modification or expiration of any such Company Permits is pending or reasonably foreseeable (other than expiration upon the end of any term).
(c)No Subject Company or, to the Knowledge of Sellers, any of the Subject Companies’ directors or employees or any other Person acting on behalf of any such Person has, with respect to the business of the Subject Companies, directly or indirectly, (1) in the case of the Subject Companies operating in the U.S. identified in Section 3.9(c) of the Sellers Disclosure Letter, taken any action that would cause such Subject Companies to be in violation of the U.S. Foreign Corrupt Practices Act of 1977, (2) in the case of the Subject Companies operating in Mexico identified in Section 3.9(c) of the Sellers Disclosure Letter, taken any action that would cause any of such Subject Companies to be in violation of the applicable anti-bribery Laws of Mexico, including any applicable Law of any locality, including any Law promulgated by the Mexican Government to implement the OECD Convention on Combating Bribery of Foreign Public Officials in Business Transactions,
30
and (3) in the case of Subject Companies operating outside the U.S. and Mexico, taken any action that would cause such Company Companies to be in violation of the applicable anti-bribery Laws of the places where such Subject Companies operate or any other Law applicable to the conduct of business with Governmental Entities or agents or representatives thereof.
Section 3.10 Litigation. Except as set forth in Section 3.10 of the Sellers Disclosure Letter, the Subject Companies are not party to, and have not received written notice of, any action, claim, demand, proceeding, audit or investigation of any nature, whether civil, criminal, administrative, regulatory or otherwise, by or before any court, tribunal, arbitrator or other Governmental Entity or any other Person (a “Proceeding”), and no such Proceeding is pending or, to the Knowledge of the Sellers, threatened (i) against, relating to or involving any of the Subject Companies or any properties or assets (including Permits) owned, leased or used by the Subject Companies; or (ii) that challenges, or that may have the effect of preventing, delaying, making illegal or otherwise interfering with, any of the transactions contemplated hereby, and to the Knowledge of the Sellers, no event has occurred or condition or circumstance exists that may give rise to or serve as a basis for the commencement of any Proceeding referenced in this Section. No Proceedings, whether voluntary or involuntary, are pending or to the Knowledge of the Sellers threatened against any of the Subject Companies or any Seller, nor are any of the Subject Companies or any Seller contemplating any such Proceedings, under the bankruptcy Laws and/or receivership or similar Laws of the United States, or any State thereof, or of any other country or jurisdiction.
Section 3.11 Tax Matters. Except as disclosed in Section 3.11 of the Sellers Disclosure Letter:
(a) (i) The Subject Companies have timely filed all Tax Returns that they are required to file, and have paid all Taxes thereon as owing; (ii) the Subject Companies have properly and timely withheld, collected and deposited all Taxes that are required to be withheld, collected and deposited under Law; (iii) all statutory Tax reports have been timely filed before the Tax Authorities by the external auditors of the Subject Companies, and the Subject Companies have maintained all documents and records relating to such Tax Returns as required by Law; and (iv) all Tax Returns for all open periods filed by the Subject Companies correctly reflect in all material respects the matters required to be reported therein including, where appropriate, income, expenses, deductions, credits, loss carryovers and Taxes due.
(b) Section 3.11 (b) of the Sellers Disclosure Letter lists all Income Tax Returns filed with respect to the Subject Companies for taxable periods ended on or after December 31, 2007, indicates those Income Tax Returns that have been audited, and indicates those Income Tax Returns that currently are the subject of audit. Sellers have delivered to Purchasers correct and complete copies of all federal Income Tax Returns, examination
31
reports, and statements of deficiencies assessed against or agreed to by the Subject Companies since December 31, 2007.
(c) None of the Subject Companies has waived any statute of limitations in respect of Taxes or agreed to any extension of time with respect to a Tax assessment or deficiency.
(d) None of the Subject Companies is a party to any Income Tax allocation or sharing agreement.
(e) For all transactions between the Subject Companies and any non-resident Person with whom any of the Subject Companies was not dealing at arm’s length during a taxation year commencing after 1998 and ending on or before the Closing Date, each of the Subject Companies has made or obtained records or documents that meet the requirements of paragraphs 247(4)(a) to (c) of the Income Tax Act of Canada.
(f) When so required, each Subject Company is duly registered under subdivision (d) of Division V of Part IX of the Excise Tax Act of Canada with respect to the goods and services tax and harmonized sales tax and the registration of the Company is 10198-0837-RC0002.
(g) There are no Tax Audits pending or, to the Knowledge of Sellers, threatened with respect to any Tax Returns or Taxes due from (whether as a result of an assertion of a deficiency or otherwise) of any of the Subject Companies.
(h) The Financial Statements provide for reserves and allowances, in each case adequate to satisfy all Taxes payable (including Taxes accrued or accruable but not yet required to be paid) relating to the Subject Companies for all taxable periods or portions thereof through the Closing.
(i) None of the Subject Companies has received a Tax ruling or entered into a closing agreement or other agreement relating to Taxes with any Governmental Entity which would apply after the Closing Date.
(j) To the Knowledge of Sellers, all transactions entered into by any of the Subject Companies with any related party during any period for which the statute of limitations for any Tax has not expired or for which a taxable year remains open have been carried out in accordance with applicable Tax Laws, and all of the Subject Companies have complied with all applicable transfer pricing disclosure, documentation, reporting or other requirements.
32
(k) Sellers have delivered to the Company the documents described in Article 26, Section XI of the Mexican Federal Fiscal Code (Código Fiscal de la Federación) in order to be registered as shareholders of the Company, and the Company does not have joint and several liability with respect to due taxes, if any, arising from the acquisition of the Company’s shares by the Sellers.
Section 3.12 Personal Property. Except as disclosed in Section 3.12 of the Sellers Disclosure Letter, each of the Subject Companies has good title to, or a valid interest in, or right to use, as applicable, all personal property used in its business (including machinery and equipment), in each case, free and clear of any Liens other than Permitted Liens (the “Company Personal Property”). The Company Personal Property is in good operating condition, ordinary wear and tear excepted.
Section 3.13 Intellectual Property.
(a) Section 3.13 of the Sellers Disclosure Letter sets forth a true and complete list, as of the date of this Agreement, of all Intellectual Property owned by the Subject Companies, and a description of any royalties paid or received by the Subject Companies with respect thereto. The Subject Companies own or have the right to use, free and clear of all Liens, except for Permitted Liens, all Intellectual Property necessary to conduct their respective businesses substantially as presently conducted except where the failure to so own or have such right, or the presence of such Liens, would be immaterial to the Subject Companies, taken as a whole.
(b) Except as disclosed in Section 3.13(b) of the Sellers Disclosure Letter, the Subject Companies have not received written notice of any claim challenging the use or ownership by the Subject Companies of any Intellectual Property, except for claims that would be immaterial to the Subject Companies, taken as a whole.
(c) To the Knowledge of Sellers, the Subject Companies use of Trademarks and Patents does not infringe any Trademark or Patent, as the case may be, of any third party. During the past two years no third party has made any written claim or demand or instituted any Proceeding against any Subject Company, or to the Knowledge of Sellers, threatened the same, and neither Seller nor any of Subject Company has received any written notice, that (i) challenges the rights of the Subject Companies in respect of any of the Patents or Trademarks utilized by the Subject Companies or (ii) asserts that the operation of the business of any Subject Company is or was infringing, misappropriating or otherwise violating the intellectual property rights of any third party. None of the Patents or Trademarks utilized by the Subject Companies is subject to any outstanding order, ruling, decree, judgment or stipulation by or with any Governmental Entity.
33
Section 3.14 Insurance.
(a) Section 3.14(a) of the Sellers Disclosure Letter sets forth a list, as of the date hereof, of all material insurance and bonds policies maintained by the Subject Companies or with respect to which a Subject Company is a named insured or otherwise the beneficiary of coverage (collectively, the “Insurance Policies”). Except as disclosed in Section 3.14(a) of the Sellers Disclosure Letter, the Insurance Policies are valid and in full force and effect. There is no material Proceeding by any Subject Company under any of such policies or bonds as to which coverage has been denied or disputed by the underwriters of such policies or bonds.
(b) Section 3.14(b) of the Sellers Disclosure Letter sets forth an accurate and complete list, as of the date hereof, of all pending claims and the claims history of the Subject Companies for the past three (3) years (including with respect to insurance obtained but not currently maintained).
Section 3.15 Employee Benefits and Labor Relations.
(a) Each employee benefit plan within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), and each other severance pay, salary continuation, bonus, incentive, stock option, retirement, profit sharing, deferred compensation or other employee benefit plan, contract, program, fund, or arrangement (whether written or oral) and any trust, escrow, or similar agreement related thereto, in each case maintained, contributed to, or required to be contributed to, by any Subject Company or any organization which, together with any Subject Company, would be treated as a “single employer plan” within the meaning of Section 414(b) or (c) of the Code (an “ERISA Affiliate”) or to which any Subject Company or ERISA Affiliate contributes (or has any obligation to contribute) or is a party as of the date hereof, excluding any Non-U.S. Employee Benefit Plan (as defined below)(collectively, the “U.S. Employee Benefit Plans”) is listed on Section 3.15(a)(i) of the Sellers Disclosure Letter. Except as set forth in Section 3.15(a)(ii) of the Sellers Disclosure Letter: (i) each U.S. Employee Benefit Plan (other than any U.S. Employee Benefit Plan that is a “multiemployer plan,” within the meaning of Section 4001(a)(3) of ERISA, covered by Title IV of ERISA (a “U.S. Multiemployer Plan”)) is in compliance in all material respects with applicable Law and has been administered and operated in all material respects in accordance with its terms; (ii) each U.S. Employee Benefit Plan (other than any U.S. Multiemployer Plan) which is intended to be “qualified” within the meaning of Section 401(a) of the Code is so qualified, has received a favorable determination letter or opinion letter from the Internal Revenue Service (“IRS”) or is comprised of a master or prototype plan that has received a favorable opinion letter from the IRS, and, to the Knowledge of Sellers, no event has occurred and no condition exists which could reasonably be expected to result in the revocation of such qualified status or any such determination letter or opinion letter; (iii) no Subject Company,
34
nor to the Knowledge of Sellers, any other Person has breached any fiduciary duty under any applicable Law with respect to any U.S. Employee Benefit Plan; (iv) the actuarial present value of the accumulated plan benefits (whether or not vested) under any U.S. Employee Benefit Plan covered by Title IV of ERISA (other than any U.S. Multiemployer Plan), as of the close of its most recent plan year did not exceed the fair value of the assets allocable thereto; (v) no U.S. Employee Benefit Plan covered by Title IV of ERISA (other than any U.S. Multiemployer Plan) has been terminated and no proceedings have been instituted to terminate or appoint a trustee to administer any such plan; (vi) no “reportable event” (as defined in Section 4043 of ERISA) has occurred with respect any U.S. Employee Benefit Plan covered by Title IV of ERISA (other than any U.S. Multiemployer Plan); (vii) no U.S. Employee Benefit Plan (other than any U.S. Multiemployer Plan) subject to Section 412 of the Code or Section 302 of ERISA has failed to satisfy the minimum funding standard within the meaning of Section 412 of the Code or Section 302 of ERISA, or obtained a waiver of any minimum funding standard or an extension of any amortization period under Section 412 of the Code or of ERISA; (viii) the Subject Companies and each ERISA Affiliate have made all contributions to each U.S. Multiemployer Plan required by the terms of each such U.S. Multiemployer Plan or any collectively bargained agreement; (ix) none of the Subject Companies nor any ERISA Affiliate has incurred any unsatisfied withdrawal liability under Part 1 of Subtitle E of Title IV of ERISA to any U.S. Multiemployer Plan and none of the Subject Companies nor any ERISA Affiliate would be subject to any such withdrawal liability if, as of close of the most recent fiscal year of any such plan ended prior to the date hereof, any Subject Company or any ERISA Affiliate were to engage in a complete withdrawal (as defined in Section 4203 of ERISA) or partial withdrawal (as defined in Section 4205 of ERISA) from any such plan; (x) no Subject Company, nor, to the Knowledge of Sellers, any other “disqualified person” or “party in interest” (as defined in Section 4975(e)(2) of the Code and Section 3(14) of ERISA, respectively) has engaged in any transactions in connection with any U.S. Employee Benefit Plan that could reasonably be expected to result in the imposition of a penalty pursuant to Section 502 of ERISA, damages pursuant to Section 409 of ERISA or a tax pursuant to Section 4975 of the Code; and (xi) no liability, claim, action or litigation, has been made, commenced or, to the Knowledge of Sellers, threatened with respect to any U.S. Employee Benefit Plan (other than routine claims for benefits payable in the ordinary course, and appeals of denied such claims).
(b) Each employee benefit plan maintained by the Subject Companies, or to which any Subject Company contributes (or has an obligation to contribute) as of the date hereof, outside the U.S. primarily for the benefit of employees residing outside the U.S., but excluding any such plan sponsored in whole or in part by any government, governmental entity or union or employee organization or any other person other than any of the Subject Companies (collectively, the “Non-U.S. Employee Benefit Plans”) is listed on Section 3.15(b)(i) of the Sellers Disclosure Letter. Except as set forth in Section 3.15(b)(ii) of the Sellers Disclosure Letter: (i) each Non-U.S. Employee Benefit Plan is in compliance in all material respects with applicable Law and has been administered and
35
operated in all material respects in accordance with its terms; (ii) each Non-US Employee Benefit Plan which is intended to qualify for special tax treatment meets the requirements for such treatment and no event has occurred and no condition exists that would reasonably be expected to result in the loss or revocation of such status; (iii) no Subject Company, nor, to the Knowledge of Sellers, any other person has breached any fiduciary duty under applicable law with respect to any Non-U.S. Employee Plan; (iv) no claim, action or litigation has been made, commenced or, to the Knowledge of Sellers, threatened in writing with respect to any Non-U.S. Employee Benefit Plan (other than routine claims for benefits payable in the ordinary course, and appeals of such denied claims); (v) each Non-U.S. Employee Benefit Plan that provides for pension benefits is funded in compliance with all applicable Laws; and (vi) each Non-U.S. Employee Benefit Plan required to be registered with applicable Governmental Entities has been so registered and has been maintained in good standing with the applicable Governmental Entities. The consummation of the transactions contemplated by this Agreement will not result in (x) any obligation of any member of the Subject Company to make any compensation or benefit, (y) an increase in the amount of compensation or benefits or (y) the acceleration of the vesting or timing of payment of any compensation or benefit, in each case, payable to or in respect of any Employee.
(c) Section 3.15(c) of the Sellers Disclosure Letter sets forth all of the collective bargaining agreements with labor unions to which any of the Subject Companies is a party or bound as of the date hereof. The consent or the consultation of or the formal rendering of advice by the employee representative bodies referenced in Section 3.15(c) of the Sellers Disclosure Letter is not required to execute this Agreement or to consummate the transactions contemplated hereby. Except as set forth in Section 3.15(c) of the Sellers Disclosure Letter, there has not been, there is not presently pending or existing, and to the Knowledge of Sellers there is no threatened, (i) strike, slowdown, picketing, or work stoppage, or (ii) any Proceeding against or affecting any member of the Subject Companies relating to the alleged violation of any Law pertaining to labor relations or employment matters, including any charge or complaint filed by an employee or union with the Secretaría del Trabajo y Previsión Social, Junta Federal y/o Local de Conciliación y Arbitraje or any comparable Governmental Entity, organizational activity, or other labor or employment dispute against or affecting any member of the Subject Companies or their premises. Each of the Subject Companies has complied in all material respects with all Laws relating to employment, equal employment opportunity, nondiscrimination, immigration, wages, hours, benefits, collective bargaining, the payment of social security and similar Taxes, occupational safety and health, and plant closing including all obligations of the IMSS and SAR. Except as set forth in Section 3.15(c) of the Sellers Disclosure Letter, no Subject Companies member is liable for the payment of any compensation, damages, Taxes, fines, penalties, or other amounts, however designated, for failure to comply with any of the foregoing Laws.
36
Section 3.16 Transactions with Related Parties.
(a) Section 3.16(a) of the Sellers Disclosure Letter sets forth a list of all Related Party Transactions existing as of the date hereof.
(b) Except as set forth in Section 3.16(b) of the Sellers Disclosure Letter, (i) no shareholder or officer of any Subject Company or any of their respective Affiliates nor any family member within the first two degrees in ascending or descending line, and within the first four degrees collaterally, of any of the foregoing Persons has any direct or indirect ownership or other interest in any Person with which any of the Subject Companies competes or has a business relationship; (ii) no Seller or Affiliate of any Seller nor any family member within the first two degrees in ascending or descending line, and within the first four degrees collaterally of any of the foregoing Persons owns or holds title to or possession, directly or indirectly, of any asset or Permit used or required for the operation of the Subject Companies’ business; and (iii) there are no outstanding obligations (whether under Contract or otherwise) between any Subject Company and such Seller or any of its Affiliates (other than the Subject Companies).
(c) Except as set forth on Section 3.16(c) of the Sellers Disclosure Letter, none of the Subject Companies are indebted to any of their shareholders, employees or directors (or to their family members within the first two degrees in ascending or descending line, and within the first four degrees collaterally) in any amount whatsoever, other than for salaries, benefits and other compensation incurred in the Ordinary Course of Business. Except as set forth on Section 3.16(c) of the Sellers Disclosure Letter, no shareholder, employee or director (nor to their family members within the first two degrees in ascending or descending line, and within the first four degrees collaterally) is indebted to any of the Subject Companies in any amount whatsoever.
Section 3.17 Company Contracts.
(a) Section 3.17(a) of the Sellers Disclosure Letter lists those Contracts (“Company Contracts”) to which the Subject Companies are as of the date hereof, a party or by which the Subject Companies or any of their assets are bound or otherwise subject, and that:
(i)create (A) any annual payment obligation of any of the Subject Companies of more than $150,000 (or the equivalent amount in another currency) annually or (B) aggregate payment obligations of the Subject Companies of more than $250,000 (or the equivalent amount in another currency);
37
(ii)provide for annual capital expenditures in excess of $250,000 individually, or in the aggregate, or for the disposition of any portion of the assets or business of the Subject Companies in excess of $300,000;
(iii)is a customer, distribution, supply or agency Contract which is: (A) reasonably likely to involve consideration of more than $150,000, in the aggregate, over the term of such Contract; (B) has a remaining term of six (6) months or more; or (C) is an agreement with a concessionaire;
(iv)is a partnership, joint venture or other similar Contract;
(v)is a Contract whereby any of the Subject Companies has granted to any Person any right to use any Company Intellectual Property and any Contract whereby any of the Subject Companies has been granted any right by any Person to license and/or use Intellectual Property (“IP Licenses”);
(vi)is a Contract to which a Governmental Entity is a party;
(vii)limits or restricts any Subject Company from competing, engaging in any business in any jurisdiction or from owning, operating, selling, transferring, pledging or otherwise disposing of or encumbering any of its assets or in any way participating in any business (in any capacity) (other than agreements principally with respect to another subject matter that contain, as part thereof, confidentiality or secrecy provisions);
(viii)evidences or governs Funded Indebtedness of any of the Subject Companies;
(ix)grants to any Person an option or a right of first refusal, first-offer or similar preferential right to purchase or acquire any of the Subject Companies’ assets (tangible or intangible);
(x)creates any mortgage, pledge, conditional sales contract, security agreement, factoring agreement or other similar agreement with respect to any of the Company Personal Property or the Real Properties;
(xi)relates to any interest rate, foreign currency swap, derivative, hedging or similar transaction; and
(xii)sets out any outstanding guaranty or indemnification obligation, direct or indirect, by the Subject Companies.
38
(b) Notwithstanding anything to the contrary in this Section 3.17, “Company Contracts” shall not include immaterial Contracts that will be fully performed or satisfied as of or prior to Closing.
(c) (i) All material Company Contracts are valid, binding and in full force and effect and constitute legal, valid and binding obligations of the Subject Companies and, to the Knowledge of Sellers, of the other parties thereto, and are enforceable by and against the Subject Companies in accordance with their respective terms (except as such enforceability may be affected by bankruptcy, concurso mercantil, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting creditors’ rights generally); (ii) neither the Subject Companies nor, to the Knowledge of Sellers, any other Person is in material breach or violation or default under any Company Contract; and (iii) to the Knowledge of Sellers, no event has occurred which would result in a material breach of or default under, require any consent or other action by any Person under, or give rise to any penalty or right of termination, cancellation or acceleration of any right or obligation of the Subject Companies or any Person or to a loss of any material benefit to which any of the Subject Companies is entitled under (in each case, with or without notice or lapse of time, or both) any Company Contract.
Section 3.18 Real Properties; Real Property Leases.
(a) Section 3.18(a) of the Sellers Disclosure Letter lists all real property owned by any of the Subject Companies (“Real Properties”), including (i) location and dimensions and (ii) the number of the public deed pursuant to which such parcel of Real Property was acquired by a member of the Company Group together with the registration data before the corresponding Public Registry of Property. The respective Subject Company has good and marketable title over the respective Real Properties, which title is free and clear of any Liens except for Permitted Liens and those Liens identified in Section 3.18(a) of the Sellers Disclosure Letter.
(b) Section 3.18(b) of the Sellers Disclosure Letter contains a list as of the date hereof of all (i) real property leased to or from the Subject Companies; and (ii) leases of material real property (collectively, the “Real Property Leases”) to which any of the Subject Companies is a party (as lessee, sublessee, sublessor or lessor). All Real Property Leases are valid, binding and in full force and effect and constitute legal, valid and binding obligations of the Subject Companies and, to the Knowledge of Sellers, of the other parties thereto, and are enforceable by and against the Subject Companies in accordance with their respective terms (except as such enforceability may be affected by bankruptcy, concurso mercantil, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting creditors’ rights generally); (ii) neither the Subject Companies nor, to the Knowledge of Sellers, any other Person is in material breach or violation or default under any such Real Property Lease.
39
(c) There are no limitations or contractual or legal restrictions that preclude or restrict the ability to use any parcel of Real Property or any buildings, structures or improvements located thereon for the uses for which they are currently being used.
(d) Except as set forth on Section 3.18(d) of the Sellers Disclosure Letter, the Subject Companies do not own, lease, operate or otherwise use, nor have the Subject Companies owned, leased, operated or otherwise used, any manufacturing plant or facility, blending station or distribution facility.
Section 3.19 Bank Accounts. Section 3.19 of the Sellers Disclosure Letter contains a complete and accurate list showing (i) the name and address of each bank or other financial institution in which each of the Subject Companies has an account or safe deposit box, the number and nature of any such account or any such box and the names of all Persons authorized to draw thereon or to have access thereto; and (ii) the names of all Persons, if any, holding powers of attorney or other authority (express, implied or ostensible) from any of the Subject Companies to enter into any contract or commitment on each of their behalf and a summary statement of the terms thereof.
Section 3.20 Environmental Matters.
(a) Except as set forth in Section 3.20(a) of Sellers Disclosure Letter:
(i) each Subject Company is currently, and in the past five (5) years has been, in compliance in all material respects with all Environmental Laws;
(ii) each Subject Company possesses and is in compliance with all applicable permits, approvals, licenses, and certificates required under Environmental Law to operate its business (the “Environmental Approvals”) are in full force and effect and there is no Claim or proceeding in existence or in progress or, to the Knowledge of Sellers, threatened, which may result in the cancellation, revocation, temporary or permanent suspension or material modification of any such Environmental Approval;
(iii) none of the Subject Companies has received any written notice from any Governmental Entity or third party, and to the Knowledge of Sellers, there is no pending or threatened claim, litigation, administrative proceeding, or investigation with respect to any actual or alleged noncompliance by any Subject Company with, or Liability of any Subject Company under, Environmental Laws;
(iv) none of the Subject Companies is undertaking or has planned any investigation, remedial action or other works in respect of any Hazardous Substance
40
present or allegedly present in soil, sub-soil, surface water, sub-surface water or groundwater at, in, on, under, or in any way materially affecting any Real Property or any other property owned or occupied by any of the Subject Companies or any other location, whether voluntarily or pursuant to a regulatory or other notice or mandate; and
(v) the Real Property is not and, to the Knowledge of Sellers, has not at any time been deemed by any Governmental Entity or under any Environmental Laws, as a Hazardous Substances disposal site, Hazardous Substances handling facility, contaminated site, environmental emergency or environmental contingency.
(b) Each of the Subject Companies have made available to the Purchaser true and complete copies and results of any material reports, certificates, studies, analyses, tests, or monitoring initiated by and in the possession of any of the Subject Companies pertaining to Hazardous Substances at, in, on, or under any property owned or occupied by any of the Subject Companies.
Section 3.21 Brokers. Except for HSBC Securities (USA) Inc. and X.X. Xxxxxx Securities LLC, no broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission from the Sellers or the Subject Companies in connection with the transactions contemplated by this Agreement based upon arrangements made by or on behalf of the Subject Companies or for which any Subject Company has any Liabilities.
Section 3.22 Inventory. All inventory of the Subject Companies, whether or not reflected in the Financial Statements consists of a quality and quantity usable and salable in the Ordinary Course of Business, all of which has been written off or written down to net realizable value in the Financial Statements, or on the accounting records of the Subject Companies as of the Closing, as the case may be. The quantities of each item of inventory (whether raw materials, work-in-process, or finished goods) are not excessive, but are reasonable in the present circumstances of the Subject Companies.
Section 3.23 Proceedings. Sellers have not received written notice of any Proceedings that are pending that challenge, or that may have the effect of preventing, delaying, making illegal any of the transactions contemplated by this Agreement and, to the Knowledge of Sellers, no such Proceedings are threatened.
41
Section 3.24 Product Liability.
(a) During the past five (5) years, no product liability, product warranty, recall or similar claims have been made against any Subject Company. No Subject Company has received (in connection with any product manufactured, sold or distributed by, or in connection with any service provided in connection with, the business of the Subject Companies) notice of any (i) claim or allegation of personal injury, death, or property or economic damages, (ii) product recall, (iii) claim for punitive or exemplary damages, (iv) claim for contribution or indemnification, or (v) claim for injunctive relief.
(b) To the Knowledge of Sellers, no Subject Company, nor any predecessor or Affiliate thereof, has manufactured, sold, distributed, marketed or installed any asbestos or lead containing products, where the asbestos or lead quantities or qualities in such products would have been in breach of the standards permitted by the applicable Law in force during such period. No Subject Company has in the last twenty (20) years received (in connection with any product containing asbestos or lead manufactured, sold or distributed by the business of the Subject Companies) notice of any (i) claim or allegation of personal injury, death, or property or economic damages, (ii) product recall, (iii) claim for punitive or exemplary damages, (iv) claim for contribution or indemnification or (v) claim for injunctive relief, in each case, related to asbestos or lead containing products.
Section 3.25 No Additional Representations. Except for the representations and warranties contained in this Article III, neither such Seller nor any other Person on behalf of such Seller makes any express or implied representation or warranty with respect to such Seller or the Subject Companies or with respect to any other information provided to Purchasers in connection with the transactions contemplated by this Agreement, and each Purchaser acknowledges that it has not relied on any representation or warranty by any Person in entering into this Agreement other than the representations and warranties set forth in this Article III. Except as expressly set forth herein, the condition of the assets of the Subject Companies shall be “as is” and “where is” and such Seller makes no warranty of merchantability, suitability, fitness for a particular purpose or quality with respect to any of the tangible assets of the Subject Companies or as to the condition or workmanship thereof or the absence of any defects therein, whether latent or patent. Such Seller is not, directly or indirectly, making any representations or warranties regarding any pro-forma financial information, financial projections or other forward-looking statements of Subject Companies. It is understood that any Due Diligence Materials made available to Purchasers or their Affiliates or their respective Representatives do not, directly or indirectly, and shall not be deemed to, directly or indirectly, contain representations or warranties of such Seller or its Affiliates or its Representatives.
42
Article IV
REPRESENTATIONS AND WARRANTIES OF PURCHASERS
Purchasers hereby jointly represent and warrant, as of the date hereof and as of the Closing, to the Sellers as follows:
Section 4.1 Due Organization, Good Standing and Corporate Power of Purchasers.
Purchasers are validly existing and in good standing (or the equivalent thereof) under the Laws of Ohio and Curacao, respectively, and have the requisite corporate power and authority and all necessary governmental licenses, authorizations, permits, consents and approvals to own, lease and operate their properties and to carry on their businesses as now being conducted. Each Purchaser is duly qualified or licensed to do business and is in good standing in each jurisdiction in which the nature of its business or the ownership or leasing of its properties makes such qualification or licensing necessary. Neither Purchaser is in violation of any of the provisions of its certificate of incorporation or by-laws.
Section 4.2 Authorization; Non-contravention.
(a) Each Purchaser has the requisite corporate power and authority and has taken all corporate or other action necessary to execute and deliver this Agreement, the Escrow Agreement and all other instruments and agreements to be delivered by each Purchaser as contemplated hereby and thereby, to perform its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. The execution, delivery and performance by each Purchaser of this Agreement, the Escrow Agreement and all other instruments and agreements to be delivered by Purchasers as contemplated hereby and thereby, the consummation by them of the transactions contemplated hereby and thereby and the performance of their obligations hereunder and thereunder have been duly authorized and approved by the board of directors of each Purchaser. This Agreement and the Escrow Agreement have been, and all other instruments and agreements to be executed and delivered by Purchasers as contemplated hereby and thereby will be, duly executed and delivered by each Purchaser. Assuming that this Agreement and the Escrow Agreement constitute legal, valid and binding obligations of Sellers and each other Person (other than Purchasers) party thereto, this Agreement and the Escrow Agreement constitute legal, valid and binding obligations of each Purchaser, enforceable against each Purchaser in accordance with their terms, except as such enforcement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar Laws affecting the enforcement of creditors’ rights generally. Assuming that all other instruments and agreements to be delivered by Purchasers as
43
contemplated hereby and thereby constitute legal, valid and binding obligations of Sellers and each other Person (other than Purchasers) party thereto, such instruments and agreements will constitute legal, valid and binding obligations of Purchaser enforceable against Purchasers in accordance with their terms, except as such enforcement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar Laws affecting the enforcement of creditors’ rights generally.
(b) The execution and delivery of this Agreement and all other instruments and agreements to be delivered by Purchasers as contemplated hereby do not, and the consummation of the transactions contemplated hereby and thereby will not (i) conflict with any of the provisions of the certificate of incorporation or by-laws or equivalent charter documents of each Purchaser, as amended to the date of this Agreement; (ii) conflict with or result in breach of, or constitute a default under, or result in the acceleration of any obligation or loss of any benefits under, any material Contract or other instrument to which each Purchaser is a party or by which each Purchaser or any of its properties or assets is bound; or (iii) subject to (A) the applicable Antitrust Laws and (B) the approval of the board of directors of each Purchaser, contravene any Law or any Order applicable to Purchasers or by which any of their properties or assets are bound.
Section 4.3 Consents and Approvals. Assuming all required Antitrust Filings are made, and clearances thereunder received, no consent of or filing with any Governmental Entity or any other Person must be obtained or made in connection with (i) the execution and delivery of this Agreement by Purchasers; or (ii) the consummation by Purchasers of the transactions contemplated by this Agreement, other than the approval of the Foreign Investment Approval.
Section 4.4 Broker’s or Finder’s Fee. Except for Xxxxxxx Sachs & Co. no agent, broker, Person or firm acting on behalf of Purchasers is or shall be entitled to any fee, commission or broker’s or finder’s fees in connection with this Agreement or any of the transactions contemplated hereby from any of the Purchasers.
Section 4.5 Financing. Purchasers, on the Closing Date, will have sufficient funds available, in each of such cases so as to enable them to consummate the purchase of the Shares and the other transactions contemplated by this Agreement.
Section 4.6 Solvency. Assuming the accuracy of all of the Sellers’ representations and warranties, immediately after giving effect to the transactions contemplated by this Agreement, Purchasers and their respective Subsidiaries shall be Solvent. For purposes of this Agreement, “Solvent” when used with respect to any Person, means that, as of any date of determination, (a) the Present Fair Salable Value of its assets will, as of such date, exceed all of its liabilities, contingent or otherwise, as of such date, (b) such Person will not have, or have access to, as of such date, an unreasonably small amount of capital for the business
44
in which it is engaged or will be engaged and (c) such Person will be able to pay its debts as they become absolute and mature, in the Ordinary Course of Business, taking into account the timing of and amounts of cash to be received by it and the timing of and amounts of cash to be payable on or in respect of its indebtedness, in each case, after giving effect to the transactions contemplated by this Agreement. For purposes of the definition of “Solvent” (i) “debt” means liability on a “claim” and (ii) “claim” means (A) any right to payment, whether or not such a right is reduced to judgment, liquidated, unliquidated, fixed, contingent, matured, unmatured, disputed, undisputed, secured or unsecured or (B) the right to an equitable remedy for a breach in performance if such breach gives rise to a right to payment, whether or not such equitable remedy is reduced to judgment, liquidated, unliquidated, fixed, contingent, matured, unmatured, disputed, undisputed, legal, equitable, secured or unsecured. “Present Fair Salable Value” means the amount that may be realized if the aggregate assets of such Person (including goodwill) are sold as an entirety with reasonable promptness in an arm’s length transaction under present conditions for the sale of comparable business enterprises.
Section 4.7 Proceedings. Purchasers have not received, as of the date hereof, written notice of any Proceedings that are pending that challenge, or that may have the effect of preventing, delaying, making illegal any of the transactions contemplated by this Agreement and, to the Knowledge of Purchasers, no such Proceedings are threatened.
Section 4.8 Experienced Investor. Each Purchaser (i) is an investor experienced in the ownership of businesses similar to the Subject Companies; (ii) has knowledge and experience in financial, business and investment matters as to be capable of evaluating the merits and risks of the transactions contemplated by this Agreement; and (iii) has the ability to bear the economic risks of the transactions contemplated by this Agreement.
Section 4.9 Investigation by Purchasers. Purchasers have conducted their own independent investigation, verification, review and analysis of the business, operations, assets, liabilities, results of operations, financial condition, technology and prospects of the Subject Companies, which investigation, review and analysis was conducted by Purchasers and their respective Affiliates and to the extent Purchasers deemed appropriate. In entering into this Agreement, each Purchaser acknowledges that it has relied solely upon the aforementioned investigation, review and analysis and not on any factual representations or opinions of the Sellers (except the specific representations and warranties of Sellers set forth in Article III), and each Purchaser acknowledges and agrees, to the fullest extent permitted by Law, that:
(i) Purchasers have not relied on any oral or written representation or warranty, either express or implied, as to the accuracy or completeness of (A) any of the information set forth in management presentations relating to the Subject Companies made available to Purchasers, their Affiliates or their respective
45
Representatives, in materials made available in any “data room” (virtual or otherwise), including any cost estimates delivered or made available, financial projections or other projections, in presentations by the management of the Subject Companies, in “break-out” discussions, in responses to questions submitted by or on behalf of Purchasers, their Affiliates or their respective Representatives, whether orally or in writing, in materials prepared by or on behalf of the Company, or in any other form (such information, collectively, “Due Diligence Materials”), or (B) the pro-forma financial information, projections or other forward-looking statements of the Subject Companies, in each case in expectation or furtherance of the transactions contemplated by this Agreement;
(ii) without limiting the generality of the foregoing, Sellers make no representation or warranty regarding any third party beneficiary rights or other rights which Purchasers might claim under any studies, reports, tests or analyses prepared by any third parties for the Subject Companies, even if the same were made available for review by any Purchaser or their respective Representatives; and
(iii) without limiting the generality of the forgoing, Purchasers expressly acknowledge and agree that none of the documents, information or other materials provided to them at any time or in any format by the Company or any of its Affiliates or Representatives constitute legal advice, and Purchasers waive all rights to assert that they received any legal advice from Sellers, any of their Affiliates, or any of their respective Representatives or counsel, or that it had any sort of attorney-client relationship with any of such Persons.
Section 4.10 Exclusivity of Representations. The representations and warranties made by Purchasers in this Article IV are the exclusive representations and warranties made by Purchasers. Purchasers hereby disclaim any other express or implied representations or warranties with respect to themselves or any other Person.
Article V
COVENANTS
Section 5.1 Access to Information Concerning Properties and Records. Sellers, after the date hereof through Closing Date, shall, and shall cause the Subject Companies to, (i) provide, to Purchasers and their Representatives access, as reasonably requested in writing by Purchasers, to the offices, properties, books and records of the Subject Companies (it being understood that such access will be coordinated through Primary Seller, and granted during regular business hours upon reasonable advance notice in writing, and provided that any such access by Purchasers shall not unreasonably interfere with the conduct of the business of the Subject Companies); and (ii) furnish to Purchasers and their Representatives such financial and operating data and other information relating to the Subject Companies
46
as such Persons may reasonably request; provided, that, Purchasers will not have access to (A) individual performance or evaluation records; (B) information that is subject to attorney-client privilege or other privilege; (C) information that, in the reasonable opinion of Sellers or the Subject Companies, would (1) result in a breach of confidentiality obligations to which Sellers or the Subject Companies are bound or (2) result in a violation of applicable Laws, including Antitrust Laws; and provided, further, (3) that such access shall not unreasonably disrupt the operations of the Subject Companies. No investigation by Purchasers or other information received by Purchasers shall operate as a waiver or otherwise affect any representation, warranty or agreement given or made by the Sellers hereunder.
Section 5.2 Confidentiality.
(a) Information obtained by Purchasers and their Representatives in connection with the transactions contemplated by this Agreement shall be subject to the provisions of the Confidentiality Agreement by and between the Company and Primary Purchaser, dated July 23, 2012 (the “Confidentiality Agreement”).
(b) Each Seller acknowledges that it is in possession of Confidential Material. Each Seller shall, and shall cause its current shareholders to treat confidentially and not disclose all or any portion of such Confidential Material and will use such Confidential Material solely for the purpose of consummating the transactions contemplated by this Agreement and for no other purpose. Each Seller acknowledges and agrees that such Confidential Material is proprietary and confidential in nature and may be disclosed to its Representatives only to the extent necessary for such Seller to consummate the transactions contemplated by this Agreement. If such Seller or its current shareholders are requested or required to disclose (after such Seller has used its commercially reasonable efforts (litigation excepted) to avoid such disclosure and, to the extent not prohibited by Law, after promptly advising and consulting with Purchasers about such Seller’s intention to make, and the proposed contents of, such disclosure) any of the Confidential Material (whether by deposition, interrogatory, request for documents, subpoena, civil investigative demand or similar process), to the extent not prohibited by Law, such Seller shall provide Purchasers with prompt notice of such request so that Purchasers may seek an appropriate protective order or other appropriate remedy. At any time that such protective order or remedy has not been obtained, such Seller may disclose only that portion of the Confidential Material which such Person’s counsel advises is legally required to disclose or of which disclosure is required to avoid sanction for contempt or any similar sanction, and such Seller shall exercise its commercially reasonable efforts (excluding litigation), at Purchasers’ sole cost, to obtain assurance that confidential treatment will be accorded to such Confidential Material so disclosed.
47
Section 5.3 Conduct of the Business of the Subject Companies Pending the Closing Date.
(a) Sellers agree that during the period commencing on November 9, 2012 and ending on the Closing Date, the Company shall, and shall cause each of the Company’s Subsidiaries to, conduct their respective operations (including their respective working capital practices) only in the Ordinary Course of Business consistent with past practice, including by complying in all material respects with all applicable Laws, maintaining all assets and properties of, or used by the Subject Companies, and timely filing all Tax Returns and timely paying all Taxes due as well as timely withholding and paying all Taxes required to be withheld and paid prior to the Closing Date, and to use their commercially reasonable efforts to preserve intact their respective business organizations, keep available the services of their officers and employees and maintain their respective relationships with licensors, suppliers, distributors, clients and others having business relationships with them.
(b) From November 9, 2012 until the earlier to occur of the Closing Date or such date as this Agreement is terminated in accordance with Article VII, Sellers agree that, except as (i) expressly required or permitted by this Agreement; (ii) required by applicable Law; or (iii) as otherwise consented to in advance in writing by Purchasers provided that such consents do not violate applicable Law (which consent shall not be unreasonably withheld, delayed or conditioned), Sellers shall cause the Subject Companies not to:
(i) sell any material assets of the Subject Companies or purchase any material asset, other than assets sold and purchased in the Ordinary Course of Business;
(ii) create, incur or assume any Funded Indebtedness;
(iii) grant, create, incur or suffer to exist any Liens, other than Permitted Liens, on any assets, properties or shares of capital stock of the Subject Companies;
(iv) split, combine or reclassify any of the capital stock of the Subject Companies or issue or authorize or propose the issuance of any other securities in respect of, in lieu of or in substitution for, shares of the capital stock of the Subject Companies;
(v) issue or grant options, warrants, rights to purchase, or any other instrument that is convertible into, any securities with respect to the Subject Companies;
48
(vi) repurchase, directly or indirectly, redeem or otherwise acquire any shares of the capital stock of the Subject Companies or any securities convertible into or exercisable for any shares of the capital stock thereof, except, in each case, in respect of acquisitions of shares representing the stated capital of any of the Subject Companies from third parties;
(vii) transfer, sell, dispose of, or agree to transfer, sell or dispose of, the shares of the Subject Companies, or enter into any agreement to do, or with respect to, any of the foregoing;
(viii) merge or consolidate with any other Person or acquire any amount of stock or assets of any other Person;
(ix) commence any Proceeding or file any petition in any court relating to bankruptcy, concurso mercantil, reorganization, insolvency, dissolution, liquidation or relief from debtors;
(x) grant to any Employee any increase in base salary, incentive compensation, severance benefits or aggregate employee benefits, except as may be required under existing agreements or applicable Law or in the Ordinary Course of Business;
(xi) enter into, modify or amend in any respect or terminate any Company Contract or Company Permit except for renewals, extensions or other modifications or amendments in the Ordinary Course of Business;
(xii) cause or permit any amendment, supplement, waiver or modification to or of any of their organizational documents;
(xiii) make capital expenditures in excess of $19,000,000 in the aggregate;
(xiv) prepay any accounts payable or delay or make cash payments of trade payables, other than, in the Ordinary Course of Business consistent in amount, frequency and type with past practice;
(xv) make any loan, advance or capital contribution to or investment in any Person (other than loans, advancements or capital contribution to a Company Subsidiary);
(xvi) other than in the Ordinary Course of Business, forgive, cancel, compromise, waive, release or fail to pay any debts, claims or rights in excess of $250,000 in the aggregate;
49
(xvii) change the accounting methods, practices or procedures applicable to the Subject Companies, except as required by applicable GAAP or applicable Law;
(xviii) other than in the Ordinary Course of Business, sell, transfer, assign, license or permit to lapse or abandon any Company Intellectual Property;
(xix) (a) make, change or revoke any Tax election, settle or compromise any Tax claim or Liability or enter into a settlement or compromise, or change (or make a request to any taxing authority to change) any material aspect of its method of accounting for Tax purposes, or (b) prepare or file any Tax Return (or any amendment thereof) unless such Tax Return shall have been prepared in a manner consistent with past practice and the Sellers shall have provided Purchasers a copy thereof (together with supporting papers) at least three Business Days prior to the due date thereof for Purchasers to review and approve (such approval not to be unreasonably withheld, conditioned or delayed);
(xx) declare, set aside or pay any cash or non-cash dividend or other cash or non-cash distribution with respect to its shares of stock;
(xxi) enter into, modify or terminate any collective bargaining agreement of the Subject Companies or, through negotiation or otherwise, make any commitment or incur any liability to any labor organization with respect to the Subject Companies other than as required by Law and in the Ordinary Course of Business; or
(xxii) agree, whether in writing or otherwise, to do any of the actions or omissions described in paragraph (i) through (xxi) above.
Section 5.4 Exclusive Dealing. During the period from November 9, 2012 through and including the Closing Date, Sellers shall not, and shall cause the Subject Companies and the respective Representatives and Affiliates of the Subject Companies, to refrain from taking any action to, directly or indirectly, approve, authorize, encourage, initiate, solicit, or engage in discussions or negotiations with, or provide any information to, any Person other than Purchasers and their Representatives concerning any Alternate Transaction, (as defined below) and Sellers shall prevent any of the Subject Companies from entering into any Alternate Transaction. For purposes hereof, an “Alternate Transaction” means (i) any stock purchase, merger, consolidation, reorganization, change in organizational form, spin-off, split-off, recapitalization, sale of equity interests or other similar transaction involving the Subject Companies; (ii) any sale of all or any significant portion of the assets of the Subject Companies; (iii) any other transaction in respect of the
50
Subject Companies which results directly or indirectly, in a change of control of the Subject Companies or sale of any minority equity interest in the Subject Companies; or (iv) any other transaction or series of transactions which has substantially similar economic effects, in each such case, in which transaction Purchasers do not participate. Neither Sellers nor the Subject Companies will vote their capital stock of the Subject Companies in favor of any purchase of any capital stock of the Subject Companies or any other Alternate Transaction.
Section 5.5 Commercially Reasonable Efforts; Consents. Subject to the terms and conditions contained in this Section 5.5 and Section 5.9, the Parties shall cooperate and use their respective commercially reasonable efforts to take, or cause to be taken, all appropriate action, and to make, or cause to be made, all filings necessary, proper or advisable under applicable Laws and to consummate and make effective the transactions contemplated by this Agreement, including their respective commercially reasonable efforts to obtain, prior to the Closing Date, all permits, consents, approvals, authorizations, qualifications and Orders of Governmental Entities and parties to the Company Contracts as are necessary for the consummation of the transactions contemplated by this Agreement and to fulfill the conditions to consummation of the transactions contemplated hereby set forth in Section 6.2 and Section 6.3.
Section 5.6 Public Announcements. Primary Seller and Primary Purchaser each shall (i) consult with each other before issuing any press release or otherwise making any public statement with respect to the transactions contemplated by this Agreement; (ii) provide to the other Primary Party for review a copy of any such press release or public statement; and (iii) not issue any such press release or make any such public statement prior to such consultation and review and the receipt of the prior consent of the other Primary Party, unless and only to the extent, in the reasonable judgment of such Primary Party upon the advice of its counsel, disclosure is required by applicable Law (including the periodic reporting requirements under the Exchange Act) or under the rules of any securities exchange on which the securities of such party or any of its Affiliates are listed; provided that, to the extent so required by applicable Law, the Primary Party intending to make such release shall use its commercially reasonable efforts consistent with applicable Law to consult with the other Primary Party in advance of such release with respect to the text thereof.
Section 5.7 Notification of Certain Matters. Purchasers, on the one hand, and Sellers on the other hand, shall use their respective commercially reasonable efforts to promptly notify each other of (i) any material actions, suits, claims or proceedings in connection with the transactions contemplated by this Agreement commenced or, to the Knowledge of Sellers or the Knowledge of Purchasers, threatened, against Sellers, the Subject Companies or Purchasers, as the case may be; (ii) the occurrence or non-occurrence of any fact or event which would be reasonably likely to cause any condition set forth in Article VI not to be satisfied; (iii) any notice of, or other communication relating to, a default
51
or event that, with notice or lapse of time or both, would become a default under any Company Contract; (iv) the occurrence or existence of any fact, circumstance or event which could result in any representation or warranty made by Sellers or Purchasers, as the case may be, in this Agreement or in any schedule, exhibit or certificate or delivered herewith, to be untrue or inaccurate; (v) any notice or other communication from any Person alleging that the consent of such Person is or may be required in connection with the transactions contemplated by this Agreement; or (vi) the occurrence of any event, circumstance, development, state of facts, occurrence, change or effect which has had a Material Adverse Effect or the occurrence or non-occurrence of any event, circumstance, development, state of facts, occurrence, change or effect which would not, individually or in the aggregate, result in a Material Adverse Effect; provided, however, that no such notification shall affect the representations, warranties, covenants or agreements of the Parties (or remedies with respect thereto) or the conditions to the obligations of the Parties under this Agreement; provided, further that a breach of this Section 5.7 shall not be considered for purposes of determining the satisfaction of the closing conditions set forth in Article VI or give rise to a right of termination under Article VII or a right to indemnification under Article VIII if the underlying breach or breaches with respect to which the other party failed to give notice would not result in the failure of the closing conditions set forth in Article VI or would not result in the ability of such non-breaching Party to terminate this Agreement or to obtain indemnification, as the case may be.
Section 5.8 Supplements to Schedules. Primary Seller may deliver to Primary Purchaser no later than the end of the third Business Day prior to the Closing Date a true and complete schedule of changes (the “Update Schedule”), which changes are to any of the information contained in the Sellers Disclosure Letter delivered in connection with the execution of this Agreement (including changes relating to any other representations or warranties in Article III as to which no matters have been set forth in the Sellers Disclosure Letter as of November 9, 2012 but as to which such matter would have been required to be set forth in the Sellers Disclosure Letter if such matter had existed on November 9, 2012) and which changes would render any representation or warranty inaccurate or incomplete at any time after November 9, 2012 until the Closing Date. Furthermore, the only changes which may be included on the Update Schedule are those which are related to events or circumstances that occurred after November 9, 2012.
Section 5.9 Antitrust Laws.
(a) Each Party shall use its commercially reasonable efforts to: (i) as promptly as practicable, take all actions necessary to file or cause to be filed the filings required of it or any of its Affiliates under any applicable Antitrust Laws in connection with this Agreement and the transactions contemplated hereby (the “Antitrust Filings”); (ii) obtain the required consents and clearance from Antitrust Authorities, as promptly as practicable, and in any event prior to the End Date; (iii) use their respective commercially
52
reasonable efforts to comply with (or properly reduce the scope of) any formal or informal request for additional information or documentary material received by it or any of its Affiliates from any Antitrust Authority.
(b) Each Party shall use its commercially reasonable efforts to (i) consult and cooperate with each other and consider in good faith the views of the other Party in connection with any analyses, appearances, presentations, memoranda, briefs, arguments, opinions and proposals made or submitted by or on behalf of any party in connection with proceedings under or relating to any Antitrust Laws; (ii) promptly notify the other Party of any material written communication made to or received by it from any Antitrust Authority regarding any of the transactions contemplated hereby, and, subject to applicable Law, if practicable, permit the other Party to review in advance any proposed written communication to any such Antitrust Authority and incorporate the other Party’s reasonable comments; and (iii) consult, to the extent practicable, with the other Party in advance of any material meeting or teleconference with any Governmental Entity and, to the extent not prohibited by the Governmental Entity, give the other Party the opportunity to attend and participate in such meetings or teleconferences.
(c) Purchasers shall not, and shall cause their Affiliates not to, acquire or agree to acquire, by merging with or into or consolidating with, or by purchasing a substantial portion of the assets of or equity in, or by any other manner, any business or any corporation, partnership, association or other business organization or division thereof, or otherwise acquire or agree to acquire any assets, if the entering into of a definitive agreement relating to, or the consummation of such acquisition, merger or consolidation could reasonably be expected to: (i) impose any delay in the obtaining of, or increase the risk of not obtaining, any consents of any Governmental Entity necessary to consummate the transactions contemplated hereby or the expiration or termination of any applicable waiting period; (ii) in any way increase the risk of any Governmental Entity entering an Order prohibiting or conditioning the consummation of the transactions contemplated hereby; (iii) in any way increase the risk of not being able to remove any such Order on appeal or otherwise; or (iv) in any way materially delay or prevent the consummation of the transactions contemplated hereby.
(d) Purchaser shall be responsible for the payment of all filing fees in connection with the Antitrust Filings under the Antitrust Laws.
Section 5.10 Preservation of Records. For a period of seven (7) years after the Closing Date, Purchasers shall cause the Subject Companies to preserve and retain, all corporate, accounting, tax, legal, auditing, human resources and other books and records of the Subject Companies (including (i) any documents relating to any governmental or non-governmental claims, actions, suits, proceedings or investigations; and (ii) all Tax Returns, schedules, work papers and other material records or other documents relating to the conduct
53
of the business and operations of the Subject Companies prior to the Closing Date. Notwithstanding the foregoing, during such seven-year period, Purchasers may cause the Subject Companies to dispose of any such books and records which are offered to, but not accepted by, Primary Seller. Notwithstanding any other provisions hereof, the obligations of Purchasers contained in this Section 5.10 shall be binding upon the successors and assigns of Purchasers. In the event Purchasers, or any of their respective successors or assigns, (i) consolidates with or merges into any other Person; or (ii) transfers all or substantially all of its properties or assets to any Person, then, and in each case, proper provision shall be made so that the successors and assigns of Purchasers, as the case may be, honor the indemnification and other obligations set forth in this Section 5.10.
Section 5.11 Employee Benefits.
(a) For the period commencing on the Closing Date and ending on December 31, 2013, Purchasers shall provide or cause the Subject Companies to provide to all current and former employees in the U.S. and Canada of the Subject Companies (“Company Employees”) (i) a salary or wage level and bonus opportunity at least equal to the salary or wage level and bonus opportunity to which they were entitled immediately prior to the Closing Date; and (ii) benefits, perquisites and other terms and conditions of employment that are substantially equivalent to the benefits, perquisites and other terms and conditions that they were entitled to receive immediately prior to the Closing Date (including benefits pursuant to qualified and non-qualified retirement and savings plans (as permitted by Law), medical, dental and pharmaceutical plans and programs, severance plans and policies and equity-based and incentive compensation plans). Notwithstanding the foregoing sentence (but not in limitation thereof), following the Closing Date, Purchasers may terminate or cause to be terminated the employment of any Company Employee subject to the payment and satisfaction of severance benefits, and other entitlements of such Company Employee in connection with such termination and/or under any applicable employment agreement as required by applicable Law.
(b) With respect to each employee benefit plan, policy or practice, including severance, vacation and paid time off plans, policies or practices, sponsored or maintained by Purchasers or their Affiliates, Purchasers shall cause the Subject Companies to grant or cause to be granted to all Company Employees from and after the Closing Date credit for all service with the Subject Companies, and their respective predecessors, prior to the Closing Date for all purposes (including eligibility to participate, vesting credit, eligibility to commence benefits, benefit accrual, early retirement subsidies and severance) as permitted by Law.
(c) For the period commencing on the Closing Date and ending on December 31, 2013, (i) Purchasers shall cause the Subject Companies to ensure that no limitations or exclusions as to pre-existing conditions, evidence of insurability or good
54
health, waiting periods or actively-at-work exclusions or other limitations or restrictions on coverage are applicable to any Company Employees or their dependents or beneficiaries under any welfare benefit plans in which such employees may be eligible to participate; and (ii) Purchasers shall cause the Subject Companies to provide, and the Subject Companies immediately following the Closing agree to provide or cause to be provided, that any costs or expenses incurred by Company Employees (and their dependents or beneficiaries) up to (and including) the Closing Date shall be taken into account for purposes of satisfying applicable deductible, co-payment, coinsurance, maximum out-of-pocket provisions and like adjustments or limitations on coverage under any such welfare benefit plans.
Section 5.12 Non-Competition; Non-Interference. In consideration of the purchase of the Shares by Purchasers, from the Closing Date until the third anniversary of the Closing Date, none of the Sellers nor any Person set forth in Section 5.12 of the Sellers Disclosure Letter shall:
(i) within any jurisdiction or marketing area in which the Subject Companies are doing business as of the Closing Date (including Mexico, the U.S., Canada and Central America), directly or indirectly own, manage, operate, control, be employed by, or participate in the ownership, management, operation or control of, or be connected in any manner with, any business of the type and character engaged in and competitive with that conducted by the Subject Companies within the two years prior to the Closing Date (any such business, a “Competing Business”). For these purposes, (A) ownership of securities of four percent (4%) or less of any class of securities of a publicly traded company shall not be considered to be competition to the extent such investment is merely of a passive nature and no rights to designate board members or officers in the company are granted to the Sellers or such Person pursuant to that investment, and (B) the sale of Comex branded products in Central America, other than Guatemala, shall not be considered to be competition;
(ii) persuade or attempt to persuade any potential customer or client to which the Sellers or any of the Subject Companies have made a presentation, or with which the Sellers or any of the Subject Companies have had discussions, not to purchase products sold or otherwise commercialized by any of the Subject Companies; or
(iii) solicit for Sellers or any Person other than the Purchasers or any of the Subject Companies the business of any Person which is a customer or client of the Sellers or any of the Subject Companies, or was their customer or client within one (1) year prior to the date of this Agreement or in any way interfere with the relationship between the Purchasers or any of the Subject Companies and any such Person or business relationship (including making any negative or disparaging
55
statements or communications about the Purchasers or any of the Subject Companies).
Section 5.13 Non-Solicitation of Employees. From and after the Closing Date, no Seller nor any Person set forth in Section 5.12 of the Sellers Disclosure Letter shall, for a period of three (3) years after the Closing Date, employ or solicit for employment any employee of the Subject Companies identified in Section 1.1(c) of the Sellers Disclosure Letter plus their immediate direct reports from time to time.
Section 5.14 Release.
(a) Each Seller, in each case on behalf of itself and its successors and assigns, and all Persons claiming by, through, or under any of them, jointly and severally (each, a “Related Person”), hereby fully and irrevocably releases, acquits and forever discharges Purchasers and the Subject Companies and each of their respective past, present and future officers, directors, shareholders, managing directors, representatives, employees, principals, agents, Affiliates, Subsidiaries (direct and indirect), joint ventures, predecessors, successors and assigns, (collectively, the “Released Parties”), from any and all losses, claims, demands, rights, encumbrances, contracts (other than, if applicable, employment contracts), covenants or proceedings, of whatever kind or nature in Law, equity or otherwise, whether known or unknown, and whether or not concealed or hidden, all of which such Seller or any Related Person now owns or holds or has at any time owned or held or may hereafter own or hold against any Released Party at any time related to any matter occurring on or prior to the Closing Date, relating to the business, affairs, governance or management of any Subject Company, except for (i) rights and claims arising under this Agreement, (ii) rights directly arising from such Person’s employment with any of the Subject Companies, including rights to unpaid salary, wages, health and welfare benefits, expense reimbursement consistent with company policies and rights under any employment agreement, (iii) rights to indemnification, if any, under the organizational documents of the Subject Companies, and (iv) rights and claims arising under any existing contractual relationship.
(b) Each Seller hereby irrevocably covenants to refrain from, directly or indirectly, asserting any claim or demand, or commencing, instituting or causing to be commenced, any proceeding of any kind against the Released Parties, based upon any matter released hereby.
Section 5.15 Transaction Expenses. Purchasers and Sellers shall bear their own respective costs and expenses, including fees and disbursements of attorneys, accountants, brokers, financial and other advisors and service providers, travel and entertainment expenses, and meeting and presentation expenses, incurred or to be incurred in connection with the negotiation, preparation and execution of this Agreement and the consummation
56
of the transactions contemplated hereby and the Closing. Sellers shall pay all Company Transaction Expenses.
Section 5.16 Environmental Investigations.
(a) During the period commencing on the date hereof and ending on the date immediately preceding the Closing Date, Purchasers will conduct at their own cost, Phase II environmental investigations at the Subject Companies’ facilities identified on Annex B. Purchasers shall deliver to Sellers a proposed work schedule for all facilities and a proposed scope of work for each facility. Purchasers and Sellers shall use their respective commercially reasonable efforts to promptly agree upon the schedule and scope of work at each facility. Purchasers shall use their commercially reasonable efforts to complete such investigations on or before February 28, 2013. Sellers shall use their commercially reasonable efforts to assist Purchasers in completing such investigations on or before February 28, 2013.
(b) Purchasers and their Representatives shall have the right to take soil, sediment and groundwater samples, and take other investigative measures, including the installation of groundwater monitoring xxxxx, at such facilities. The investigations shall be performed in a safe and workmanlike manner, pursuant to generally accepted standards, practices and procedures for the performance of similar activities in the industry. Purchasers or their Representatives will obtain all Permits required by applicable Laws and will otherwise comply with all applicable Laws in the performance of the investigations. At Purchasers’ request, Sellers shall use commercially reasonable efforts to assist Purchasers in their efforts to obtain such Permits. Purchasers and their Representatives will use commercially reasonable efforts to ensure that the investigation activities do not unreasonably interfere with the Subject Companies’ operations at such facilities.
(c) Sellers shall, and shall cause the Subject Companies to, (i) grant reasonable access to such facilities to conduct the investigation activities described in this Section 5.16; (ii) provide commercially reasonable cooperation to Purchasers and their Representatives in the performance of such investigation activities, and (iii) inform Purchasers and their Representatives of the location of all underground utilities and structures, including, but not limited to, cables, water lines, gas lines, electrical lines, storage tanks, piping and sewers, and any other underground obstructions.
(d) At Sellers’ request, Purchasers shall provide Sellers with a copy of any final data prepared by Purchasers’ Representatives with respect to the investigations described in this Section 5.16.
(e) Purchasers shall promptly notify Sellers of any Environmental Matter discovered during the investigation activities that requires, or is reasonably likely to require,
57
the Subject Company to notify or disclose the Environmental Matter to a Governmental Entity. If, in the opinion of Sellers’ or the Subject Company’s legal counsel, such Environmental Matter is required to be noticed or disclosed to a Governmental Entity, Sellers shall, or cause the Subject Company to, promptly notify or disclose such Environmental Matter to the appropriate Governmental Entity in accordance with applicable Law.
(f) Upon completion of the investigation activities contemplated in this Section 5.16, if the aggregate maximum potential Environmental Liabilities, in the opinion of Primary Purchaser provided on a basis consistent with normal industry practice and standards in the environmental consulting industry in the market in which the relevant Subject Company’s facility is located, exceeds $24,120,000, then the Indemnification Escrow Amount shall be increased by an amount equal to the amount by which the aggregate maximum potential Environmental Liabilities exceeds $24,120,000.
Article VI
CONDITIONS PRECEDENT
Section 6.1 Conditions to the Obligations of Each Party. The consummation of the transactions contemplated hereby are subject to the satisfaction or waiver in writing by the Primary Parties (on behalf of Sellers and Purchasers as applicable), at or before the Closing Date, of each of the following conditions precedent (condiciones suspensivas):
(i) no Governmental Entity shall have issued, enacted, entered, promulgated or enforced any Law or Order restraining, enjoining or otherwise prohibiting the transactions contemplated by this Agreement;
(ii) all consents, waivers and approvals from Governmental Entities, including clearance by the Antitrust Authorities and authorization by the Foreign Investment Authority, or third parties, if any, disclosed in Section 3.7 of the Sellers Disclosure Letter shall have been obtained;
(iii) Purchasers, Sellers and the escrow agent shall have executed and delivered a duly executed counterpart of the Escrow Agreement; and
(iv) the expiration or earlier termination of all waiting periods under applicable Antitrust Laws relating to the consummation of the transactions covered by this Agreement.
Section 6.2 Conditions to the Obligations of Purchasers. The obligations of Purchasers to consummate the transactions contemplated hereby are subject to the satisfaction or waiver by Primary Purchaser on behalf of Purchasers, on or prior to the Closing Date, of the following further conditions precedent (condiciones suspensivas):
58
(i) all of the agreements and covenants of Sellers to be performed prior to the Closing pursuant to this Agreement shall have been duly performed in all material respects;
(ii) the representations and warranties of Sellers contained in Article III shall be true and correct as of the date of this Agreement and as of the Closing Date as if made at and as of such time (other than those representations and warranties made as of a specified date, which such representations and warranties shall be true and correct in all respects as of such specified date); provided, however, that for purposes of determining the satisfaction of the condition set forth in this Section 6.2(ii), such representations and warranties (other than those representations and warranties contained in Sections 3.1, 3.2(a), 3.3, 3.5 and 3.6) shall be deemed to be so true and correct if the failure or failures of such representations and warranties to be true and correct (such representations and warranties to be read for this purpose without reference to any qualification set forth therein relating to “materiality” or “Material Adverse Effect”) do not constitute, individually or in the aggregate, a Material Adverse Effect;
(iii) Sellers shall have delivered or caused to be delivered to Primary Purchaser the items set forth in Section 2.4(b);
(iv) there shall not have occurred after the date of this Agreement any event or development with relation to Sellers or the Subject Companies that, individually or in the aggregate, has had, or would reasonably be expected to have, a Material Adverse Effect;
(v) Purchasers shall have completed the environmental investigations described in Section 5.16; and
(vi) Sellers shall have caused the Subject Companies to obtain the Permits set forth in Section 6.2(vi) of the Sellers Disclosure Letter or any other evidence, satisfactory to Purchasers in their sole discretion, demonstrating such Permits are not required pursuant to applicable Law.
Section 6.3 Conditions to the Obligations of Sellers. The obligations of Sellers to consummate the transactions contemplated hereby are subject to the satisfaction or waiver by Sellers, on or prior to the Closing Date, of the following further conditions precedent (condiciones suspensivas):
59
(i) all of the agreements and covenants of Purchasers to be performed prior to the Closing pursuant to this Agreement shall have been duly performed in all material respects;
(ii) the representations and warranties of Purchasers contained in Article IV shall be true and correct in all material respects as of the date of this Agreement and as of the Closing Date as if made at and as of such time (other than those representations and warranties made as of a specified date, which such representations and warranties shall be true and correct in all material respects as of such specified date); and
(iii) Purchasers shall have delivered or caused to be delivered to Primary Seller the items set forth in Section 2.4(c).
Section 6.4 Frustration of Closing Conditions. None of Purchasers or Sellers may rely on the failure of any condition set forth in this Article VI to be satisfied if such failure was caused by such Party’s failure to comply with its obligations hereunder, to act in good faith or such Party’s failure to use its commercially reasonable efforts to cause the Closing to occur, as required by Section 5.5.
Article VII
TERMINATION AND ABANDONMENT
Section 7.1 Termination. This Agreement may be terminated and the transactions contemplated hereby may be abandoned, at any time prior to the Closing:
(i) by mutual written consent of the Parties;
(ii) by either Sellers or Purchasers, if:
(A)any court or other Governmental Entity shall have issued, enacted, entered, promulgated or enforced any Law or Order (that is final and non-appealable and that has not been vacated, withdrawn or overturned) restraining, enjoining or otherwise prohibiting the transactions contemplated by this Agreement; provided, that the Party seeking to terminate pursuant to this Section 7.1(ii) shall have complied with their obligations, if any, under Section 5.5; or
(B)the Closing Date shall not have occurred on or prior to March 31, 2014 (the “End Date”); provided, that neither Party may terminate this
60
Agreement pursuant to this Section 7.1(ii) if such Party is in material breach of this Agreement;
(iii) by Sellers, if:
(A) any of the representations and warranties of Purchasers contained in Article IV shall fail to be true and correct, or
(B) there shall be a breach by Purchasers of any covenant or agreement of Purchasers in this Agreement,
that, in the case of either clause (A) or (B) above, (1) would result in the failure of a condition set forth in Section 6.3(i) or (ii) and (2) which is not curable or, if curable, is not cured upon the occurrence of the earlier of (x) the thirtieth (30th) day after written notice thereof is given by Sellers to Purchasers and (y) the day that is five (5) Business Days prior to the End Date; provided, that Sellers may not terminate this Agreement pursuant to this Section 7.1(iii) if Sellers are in material breach of this Agreement;
(iv) by Purchasers, if:
(A) any of the representations and warranties of Sellers contained in Article III shall fail to be true and correct, or
(B) there shall be a breach by Sellers of any covenant or agreement of Sellers in this Agreement,
that, in the case of either clause (A) or (B) above, (1) would result in the failure of a condition set forth in Section 6.2(i) or (ii) and (2) which is not curable or, if curable, is not cured upon the occurrence of the earlier of (x) the thirtieth (30th) day after written notice thereof is given by Purchasers to Sellers and (y) the day that is five (5) Business Days prior to the End Date; provided, that Purchasers may not terminate this Agreement pursuant to this Section 7.1(iv) if Purchasers are in material breach of this Agreement; or
(v) by Purchasers if any event or development with relation to the Subject Companies shall have occurred prior to the Closing Date that individually or in the aggregate has resulted in a Material Adverse Effect;
(vi) by Purchasers, if the environmental investigations described in Section 5.16 are not completed due to causes directly attributable to Sellers or causes not attributable to Purchasers, on or before February 28, 2013.
61
Section 7.2 Effect of Termination. In the event of the termination of this Agreement pursuant to Section 7.1 by Purchasers, on the one hand, or Sellers, on the other hand, written notice thereof shall forthwith be given to the other Parties specifying the provision hereof pursuant to which such termination is made, and this Agreement shall, except as set forth below, be terminated and have no effect and there shall be no liability hereunder on the part of Sellers, Purchasers or the Subject Companies, except that Section 5.2, Section 7.1, this Section 7.2 and Article X shall survive any termination of this Agreement. Nothing in this Section 7.2 shall relieve any Party of liability for any willful breach of this Agreement.
Article VIII
INDEMNIFICATION
Section 8.1 Survival of Representations and Warranties.
(a) The respective representations and warranties of Sellers, on the one hand, and Purchasers, on the other hand, contained in this Agreement shall survive the Closing until the date that is eighteen months after the Closing Date. Each covenant and other agreement of Purchasers or Sellers hereunder shall survive in accordance with its terms.
(b) No Person shall be liable for any claim for indemnification under Article VIII unless a Claim Certificate is delivered by the Person seeking indemnification to the Person from whom indemnification is sought prior to the expiration of the applicable survival period, in which case the representation, warranty, covenant or agreement which is the subject of such claim shall survive, to the extent of the claims described in such Claim Certificate only, until such claim is resolved, whether or not the amount of the Losses resulting from such breach has been finally determined at the time the notice is given.
Section 8.2 Indemnification by Sellers. Subject to the other provisions of this Article VIII, from and after the Closing Date, Sellers agree to jointly indemnify and hold harmless Purchasers, the Subject Companies and each of their respective Representatives, subsidiaries, direct and indirect parent companies, shareholders, partners, members, managers, officers and directors (the “Purchaser Indemnitees”) for any Losses suffered, incurred or paid, directly or indirectly, by them as a result of, or arising out of or related to: (i) any failure of any representation or warranty made by Sellers in Article III or in any schedule, exhibit, certificate or disclosure letter delivered pursuant to this Agreement to be true and correct on and as of the date of this Agreement or Closing Date as if made on such date (other than those made on a specified date, which shall be true and correct as of such specified date); (ii) any breach of any covenant or agreement by any of the Sellers contained in this Agreement; (iii) Environmental Liabilities; (iv) Taxes of any Subject Company that relate to periods prior to the Closing Date; (v) any Company Transaction Expenses not paid
62
by Sellers; (vi) any failure to pay the Purchase Price Adjustment to Purchaser pursuant to Section 2.3(f)(ii); (vii) (this provision has been intentionally deleted); (viii) any Liability relating to the failure of a Subject Company to hold any Permit set forth in Section 6.2(vi) of the Sellers Disclosure Letter, including any Liability incurred in obtaining such Permits; and (ix) any fraud and/or any intentional omission or intentional misrepresentation with respect to any representation or warranty made by Sellers in Article III or in any schedule, exhibit, certificate or disclosure letter delivered pursuant to this Agreement. The indemnification obligations set forth in Section 8.2(iii) shall survive the Closing and terminate on the date that is five years after the Closing Date. The indemnification obligations set forth in Section 8.2 (iv) shall survive the Closing and terminate on the 90th day following the date that the applicable statute of limitations for any such Taxes expires.
Section 8.3 Indemnification by Purchasers. Subject to the limitations set forth in this Article VIII, from and after the Closing Date, Purchasers agree to and shall jointly indemnify and hold harmless Sellers and their respective Representatives, subsidiaries, direct and indirect parent companies, shareholders, partners, members, managers, officers and directors (the “Seller Indemnitees”) for any Losses suffered, incurred or paid, directly or indirectly, by them as a result of, arising out of, or related to: (i) any failure of any representation or warranty made by Purchasers in Article IV or in any schedule, exhibit or certificate delivered pursuant to this Agreement to be true and correct on and as of the date of this Agreement or Closing Date as if made on such date (other than those made on a specified date, which shall be true and correct in all material respects as of such specified date); (ii) any breach of any covenant or agreement by any of the Purchasers contained in this Agreement; and (iii) any failure to pay the Purchase Price Adjustment to Sellers pursuant to Section 2.3(f)(i).
Section 8.4 Limitation on Indemnification.
(a) Notwithstanding anything to the contrary contained in this Agreement, (i) Sellers shall not be liable for any claim for indemnification pursuant to Section 8.2(i) unless and until the aggregate amount of Losses which may be recovered from Sellers equals or exceeds $2,000,000 (the “Deductible”), in which case Purchasers shall be entitled to recover the aggregate amount of all Losses; and (ii) the maximum aggregate amount of indemnifiable Losses which may be recovered for indemnification pursuant to Section 8.2(i), Section 8.2(iii), Section 8.2(iv) and Section 8.2(vii) shall be an amount equal to the then outstanding balance of the Indemnification Escrow Fund.
(b) Notwithstanding anything herein to the contrary (i) the limitations set forth in Section 8.1 and Section 8.4 shall not apply to Losses incurred by any Purchaser Indemnitee in connection with or arising from any breach of any representation or warranty of Sellers in Section 3.2(a), Section 3.3, Section 3.5, Section 3.6, and Section 3.21; and (ii) in no event shall any Indemnified Party be entitled to double recovery under this Agreement.
63
(c) For purposes of determining whether there has been an inaccuracy in, misrepresentation of or breach of, any representation or warranty contained in this Agreement (other than those representations and warranties contained in Section 3.8(a) and Section 3.8(d)), and for purposes of calculating any Losses resulting therefrom, the terms “material”, “materiality”, “Material Adverse Effect” or similar qualifications contained in such representations and warranties shall be disregarded.
(d) All of the funds in the Indemnity Escrow Fund from time to time shall be available to satisfy indemnity claims made by Purchaser Indemnitees under this Agreement and any indemnity claims made by any purchaser indemnitee under the Comex USA Stock Purchase Agreement.
Section 8.5 Losses Net of Insurance, etc.
(a) The amount of any Loss for which indemnification is provided under Section 8.2 or Section 8.3 shall be, without duplication, net of (i) any amount for which a reserve or accrual is included in the Closing Working Capital as finally determined pursuant to Section 2.3; (ii) any amounts recovered by the Indemnified Party pursuant to any indemnification by or indemnification agreement with any third party; or (iii) any insurance proceeds or other cash receipts or sources of reimbursement received as an offset against such Loss (each source of recovery referred to in clauses (ii) and (iii), a “Collateral Source”). Indemnification under this Article VIII shall not be available unless the Indemnified Party uses commercially reasonable efforts (litigation excepted), to seek recovery from all Collateral Sources. The Indemnifying Party may require an Indemnified Party to assign the rights to seek recovery pursuant to the preceding sentence to the extent such assignment is permitted by the relevant insurance policy; provided, however, that the Indemnifying Party will then be responsible for pursuing such claim at its own expense. If the amount to be netted hereunder in connection with a Collateral Source from any payment required under Section 8.2 or Section 8.3 is received after payment by the Indemnifying Party of any amount otherwise required to be paid to an Indemnified Party to this Article VIII, the Indemnified Party shall repay to the Indemnifying Party, promptly after such determination, any amount that the Indemnifying Party would not have had to pay pursuant to this Article VIII had such receipt been made at the time of such payment (or in the case where the Indemnified Party is a Purchaser Indemnitee, the Indemnified Party shall promptly deposit such amount with the escrow agent pursuant to the Escrow Agreement, such amount to be held pursuant to the terms of this Agreement and the Escrow Agreement and shall become part of the Indemnification Escrow Fund thereunder).
(b) Notwithstanding anything to the contrary contained in this Agreement, Sellers shall not be liable for any Losses that result from, arise out of, or relate to breaches of the representations and warranties contained in Section 3.20 or the
64
indemnification obligation contained in Section 8.2(iii) to the extent such Losses result from, arise out of, or relate to:
(i) any change in any Environmental Law on or after the Closing Date;
(ii) any voluntary disclosure to any Governmental Entity on or after the Closing Date by or on behalf of the Purchaser Indemnitees;
(iii) any investigation actions for purposes of risk assessment, corrective, removal or remedial actions or other measures taken in response to or to correct, remedy or bring into compliance any environmental conditions involving or relating to a Subject Company (“Corrective Actions”), that exceed the minimum Corrective Actions reasonably necessary to comply with any Environmental Law in effect as of the Closing Date or that are substantially more costly than the most cost-effective means that are reasonably necessary to achieve compliance with any Environmental Law in effect as of the Closing Date (including the use of reasonable and customary deed restrictions or other reasonable and customary regulatory controls where applicable).
(c) Notwithstanding anything to the contrary contained in this Agreement, with respect to any indemnification claim made for a breach of the representations and warranties provided in Section 3.20 or the indemnification obligation provided in Section 8.2(iii), Purchasers shall conduct and control any Corrective Actions required to satisfy the indemnification obligations thereunder.
(d) Purchasers acknowledge that their and the Purchasers Indemnitees’ sole and exclusive remedy against Sellers, their Affiliates or any of their officers, directors, employees, agents or partners (“Seller-Related Persons”) for any Losses relating to Environmental Liabilities is under Section 8.2 (as limited by this Section 8.5) of this Agreement. In furtherance of the foregoing, from and after the Closing Date, except for any Losses for which Seller is obligated to indemnify Purchaser Indemnitees pursuant to Section 8.2 (as limited by this Section 8.5) (i) the Purchasers hereby release, on their own behalf (and agree that their Affiliates, successors and assigns, officers, directors, employees, agents or partners rights hereunder shall be accordingly limited), to the fullest extent permitted under applicable Law, all Seller-Related Persons from any Environmental Liabilities incurred by the Purchaser Indemnitees; and (ii) the Purchasers hereby waive, on their own behalf (and agree that their Affiliates, successors and assigns, officers, directors, employees, agents and partners rights hereunder shall be accordingly limited), to the fullest extent permitted under applicable Law, any claim or remedy for Environmental Liabilities against any Seller-Related Person now or hereafter available under any applicable Environmental Law, including the Comprehensive Environmental Response,
65
Compensation, and Liability Act or similar international, foreign, federal, or regional Law, whether or not in existence on the date hereof.
(e) With respect to the Golden Parachute Obligations, Sellers shall be obligated to bear the cost of any payments made pursuant to the Golden Parachute Obligations by the corresponding Subject Company to any of the Recipients. For such purposes, Primary Purchaser shall notify Primary Seller in writing, certified by an officer of Primary Purchaser, of the termination of the labor relationship with the Recipient and the payment of the corresponding Golden Parachute Obligation with respect to such Recipient, and the Primary Parties, shall promptly upon receipt of such notice, instruct the escrow agent to release, in favor of the corresponding Subject Company, the amount corresponding to the relevant Golden Parachute Obligation from the Golden Parachute Escrow Fund. Within three (3) Business Days following on the date that is two (2) years after the Closing Date, the Primary Parties shall cause the escrow agent to release any remaining balance in the Golden Parachute Escrow Fund to Primary Seller on behalf of Sellers. The Parties hereby agree that if any Golden Parachute Obligation is paid with funds of the Golden Parachute Escrow Fund, neither Purchasers nor any of their Affiliates (including, after the Closing Date, the Subject Companies) will enter into any labor relationship with the corresponding Recipient for a period of twelve (12) months commencing on the date in which the Golden Parachute Obligation was paid to the Recipient; provided, however, that in no event shall this provision prohibit or limit in any way the hiring of such Recipient as part of an acquisition, merger, consolidation or similar transaction in which such Recipient becomes an employee of Purchasers or their Affiliates.
(f) If it is necessary for Purchasers, their Subsidiaries and/or their Affiliates to implement a Remedy in order to obtain approval of the transaction contemplated by this Agreement by the Antitrust Authorities in Mexico, and the Remedy implemented has a negative financial impact on Purchasers, their Subsidiaries and/or their Affiliates, and/or on Company, Company's Subsidiaries or Affiliates, which is attributable to such Remedy (“Remedy Impact”), Sellers shall be obligated to pay to Primary Purchaser forty percent (40%) of such Remedy Impact (“Remedy Contribution”). Any consideration received by Purchasers (either up front or through subsequent periodic payments) relating to the implementation of the Remedy shall be taken into consideration in calculating the actual amount of the Remedy Impact.
Within fifteen (15) days following the full implementation of the entire Remedy, Primary Purchaser shall provide a written notification to Primary Seller, certified by an officer of Primary Purchaser, which sets forth the total amount of the Remedy Impact and provides supporting information. Upon receipt of such notification, Primary Seller shall have a period of thirty (30) days to review such matters. Following the conclusion of such thirty (30) day period, Primary Purchaser and Primary Seller shall have a period of fifteen (15) days to mutually agree upon the amount of the Remedy Impact. Upon the conclusion of such fifteen
66
(15) day period, if Primary Seller and Primary Purchaser are able to agree upon the amount of the Remedy Impact, the Primary Parties shall jointly instruct the escrow agent to release:
(i) to Primary Purchaser on behalf of Purchasers, from the Remedy Escrow Fund, an amount equal to the Remedy Contribution; and
(ii) to Primary Seller on behalf of Sellers, the balance, if any, of the Remedy Escrow Fund.
In the event that the amount of funds in the Remedy Escrow Fund is less than the amount of the Remedy Contribution, then Sellers shall pay or cause to be paid to Primary Purchaser on behalf of Purchasers such difference.
If Primary Seller and Purchaser are unable to agree upon the amount of the Remedy Impact as set forth above, Primary Seller and Primary Purchaser shall promptly instruct the Independent Valuation Expert to determine the amount of the Remedy Impact. Primary Seller and Primary Purchaser shall use commercially reasonable efforts to cause the Independent Valuation Expert to render a decision within sixty (60) days after the submission to the Independent Valuation Expert. The determination made by the Independent Valuation Expert shall be final and binding.
Upon receipt of the Independent Valuation Expert's determination of the amount of the Remedy Impact, the Primary Parties shall jointly instruct the escrow agent to release:
(iii) to Primary Purchaser on behalf of Purchasers, from the Remedy Escrow Fund, an amount equal to the Remedy Contribution; and
(iv) to Primary Seller on behalf of Sellers, the balance, if any, of the Remedy Escrow Fund.
In the event that the amount of funds in the Remedy Escrow Fund is less than the amount of the Remedy Contribution, then Primary Seller on behalf Sellers shall pay or cause to be paid to Primary Purchaser on behalf of Purchasers such difference.
Any amount to be paid to Primary Purchaser by Primary Seller on behalf of Sellers pursuant to this Section 8.5(f) shall be paid promptly by wire transfer of immediately available funds to an account designated by Primary Purchaser in writing to Primary Seller.
If it is not necessary for Purchasers, their Subsidiaries and/or their Affiliates to implement a Remedy in order to obtain approval of the transaction contemplated by this Agreement by the Antitrust Authorities in Mexico, the Primary Parties shall promptly instruct the escrow agent to release to Primary Seller on behalf of Sellers, the Remedy Escrow Fund.
67
Section 8.6 Indemnification Procedure.
(a) Any Person entitled to indemnification pursuant to Section 8.2 or Section 8.3, including, any claim by a Person described in Section 8.7 (an “Indemnified Party”), which might give rise to indemnification hereunder, shall deliver to the Party from which indemnification is sought (the “Indemnifying Party”) a certificate (a “Claim Certificate”), which Claim Certificate shall:
(i) state that the Indemnified Party will incur liability for, or has otherwise suffered, as the case may be, Losses for which such Indemnified Party believes it is entitled to indemnification pursuant to this Agreement; and
(ii) to the extent known by the Indemnified Party specify in reasonable detail each individual item of Loss included in the amount so stated, the date such item should be paid, the basis for any anticipated Losses; provided, however, that in no event shall any Indemnified Parties failure to so specify limit its rights to indemnification hereunder.
(b) In the event that the Indemnifying Party shall object to the indemnification of an Indemnified Party in respect of any claim or claims specified in any Claim Certificate (other than a Third Party Claim, which is addressed in Section 8.7), the Indemnifying Party shall, within thirty (30) days after receipt by the Indemnifying Party of such Claim Certificate, deliver to the Indemnified Party a notice to such effect, specifying in reasonable detail the basis for such objection. In this case, the Indemnified Party shall be permitted to submit such dispute to arbitration as set forth in Section 10.9.
(c) Claims for Losses specified in any Claim Certificate to which an Indemnifying Party shall not object in writing within thirty (30) days of receipt of such Claim Certificate (other than a Third Party Claim, which is addressed in Section 8.7) and claims for Losses the validity and amount of which have been finally determined in accordance with this Agreement hereof or shall have been settled as described in Section 8.7, are hereinafter referred to, collectively, as “Agreed Claims”. Within ten (10) Business Days of the determination of the amount of any Agreed Claim, if the Indemnified Party is (i) any Seller Indemnitee, Primary Purchaser shall pay to the Indemnified Party an amount equal to the Agreed Claim by wire transfer in immediately available funds to the bank account or accounts designated by the Indemnified Party in a notice to the Indemnifying Party not less than two (2) Business Days prior to such payment, or (ii) any Purchaser Indemnitee, (A) the Primary Parties shall execute and deliver to the escrow agent in terms of the Escrow Agreement a joint written instruction instructing the escrow agent to pay to the Indemnified Party an amount equal to the Agreed Claim by wire transfer in immediately available funds to the bank account or accounts designated by Primary Purchaser in such joint written instruction and (B) to the extent the amount of the Agreed Claims exceeds the then-remaining
68
Indemnification Escrow Funds and such excess may be attributable to any of Sellers Indemnification obligations other than pursuant to Section 8.2(i), then the Primary Seller on behalf of Sellers shall pay to the Indemnified Party an amount equal to such excess amount by wire transfer in immediately available funds to the bank account or accounts designated by Primary Purchaser.
Section 8.7 Third-Party Claims.
(a) If a claim by a third party is made against any Indemnified Party (a “Third Party Claim”), and if such Indemnified Party intends to seek indemnity with respect thereto under this Article VIII, such Indemnified Party shall promptly notify the Indemnifying Party of such Third Party Claim; provided, that the failure to so notify shall not relieve the Indemnifying Party of its obligations hereunder, except to the extent that the Indemnifying Party is actually and materially prejudiced thereby. The Indemnifying Party shall have three (3) Business Days after receipt of such notice to assume the conduct and control, through counsel reasonably acceptable to the Indemnified Party at the expense of the Indemnifying Party, of the settlement or defense of such Third Party Claim; provided, that the Indemnifying Party shall permit the Indemnified Party to participate in such settlement or defense through counsel chosen by such Indemnified Party; provided, that the fees and expenses of such counsel shall be borne by such Indemnified Party, and provided, further, that the Indemnifying Party shall not be entitled to assume control of such defense and shall pay the fees and expenses of counsel retained by the Indemnified Party if (i) such Third Party Claim for indemnification relates to or arises in connection with any criminal proceeding, action, indictment, allegation or investigation against Purchasers; (ii) such Third Party Claim seeks an attachment (embargo) or other non-monetary relief against the Indemnified Party; (iii) the Indemnifying Party, in the reasonable judgment of the Indemnified Party, failed or is failing to vigorously prosecute or defend such Third Party Claim; (iv) no conflict of interest arises that prohibits, in the reasonable judgment of the Indemnified Party, a single counsel from representing both the Indemnifying Party and Indemnified Party in connection with the defense of such Third Party Claim; (v) the defense of such Third Party Claim by the Indemnifying Party will, in the reasonable judgment of the Indemnified Party, have a material adverse effect on the Indemnified Party or any business thereof; or (vi) the Indemnifying Party does not have sufficient financial resources, in the reasonable judgment of the Indemnified Party, to satisfy the amount of any adverse monetary judgment that is reasonably likely to result.
(b) If the Indemnifying Party has assumed the defense of a Third Party Claim in accordance with Section 8.7(a), the Indemnified Party shall have the right to employ separate counsel in any such action or claim and to participate in the defense of such Third Party Claim, but the fees and expenses of such counsel shall not be at the expense of the Indemnifying Party. So long as the Indemnifying Party assumes the defense of a Third Party Claim, neither the Indemnified Party nor the Indemnifying Party (except as provided in
69
Section 8.7(d)) shall admit any liability with respect to, or settle, compromise or discharge, such Third Party Claim without the other party's prior written consent (which consent shall not be unreasonably withheld, delayed or conditioned). Notwithstanding the preceding sentence, the Indemnified Party shall have the right, in its sole discretion, to pay or settle any such Third Party Claim at its own expense, provided that, in such event, the Indemnified Party shall waive any rights to indemnity hereunder in respect of the matter so settled without the Indemnifying Party's consent.
(c) If the Indemnifying Party does not notify the Indemnified Party within three (3) Business Days after the receipt of the Indemnified Party’s notice of a Third Party Claim of indemnity hereunder that it elects to undertake the defense thereof, the Indemnified Party shall have the right to contest, settle or compromise the Third Party Claim but shall not thereby waive any right to indemnity therefor pursuant to this Agreement.
(d) The Indemnifying Party shall not, except with the consent of the Indemnified Party (which consent shall not be unreasonably withheld, delayed or conditioned), enter into any settlement unless such settlement (i) is entirely indemnifiable by the Indemnifying Party pursuant to this Article VIII; (ii) includes as an unconditional term thereof the giving by the Person or Persons asserting such Third Party Claim to all Indemnified Parties of an unconditional release from all liability with respect to such Third Party Claim or consent to entry of any judgment; and (iii) does not impose any injunctive relief or other restrictions of any kind or nature on any Indemnified Party.
(e) The Indemnified Party shall make available records relating to such Third Party Claim and shall furnish, at the Indemnifying Party’s expense to the Indemnifying Party and/or its counsel, such employees of the Indemnified Party as may be reasonably necessary for the preparation of the defense of any such Third Party Claim or for testimony as witnesses in any proceeding relating to such Third Party Claim.
Section 8.8 Sole Remedy/Waiver. The Parties hereto acknowledge and agree that (i) in the event that the Closing occurs, the remedies provided for in this Agreement shall be the Parties’ sole and exclusive remedy for any breach of the representations and warranties or covenants contained in this Agreement (except with respect to any fraud and/or any intentional omission or intentional misrepresentation with respect to any representation or warranty made by Sellers in Article III or in any schedule, exhibit, certificate or disclosure letter delivered pursuant to this Agreement); and (ii) Purchasers’ sole source of recourse from Sellers for any Losses indemnifiable pursuant to Section 8.2(i), Section 8.2(iii), Section 8.2(iv), and Section 8.5(e) shall be payment from the Indemnification Escrow Fund.
Section 8.9 Release of Funds from the Indemnification Escrow Fund. Funds from the Indemnification Escrow Fund will be released from time to time in accordance with this Section 8.9:
70
(a) on the eighteen month anniversary of the Closing Date, Purchasers and Sellers shall jointly instruct the escrow agent to disburse from the Indemnification Escrow Fund to Sellers the funds that, as of such date, represent the then-remaining amount of the Indemnification Escrow Fund, if any, in excess of the sum of (i) $77,000,000 plus, (ii) any additional amount by which the Indemnification Escrow Fund was increased pursuant to Section 5.16(f) (such excess amount, the “Release Amount”), with such Release Amount to be reduced by (A) the amount, if any, which Sellers and Purchasers have instructed the escrow agent to disburse funds from the Indemnification Escrow Fund but which have not actually been disbursed as of such date, and (B) the amount of any claim submitted by any Purchaser Indemnitee prior to such date, in accordance with this Article VIII that remains pending as of such date;
(b) on the fifth anniversary of the Closing Date, Purchasers and Sellers shall jointly instruct the escrow agent to disburse from the Indemnification Escrow Fund to Sellers the funds that, as of such date, represent the then-remaining amount of the Indemnification Escrow Fund, if any, in excess of $25,000,000, with such excess amount to be reduced by (A) the amount, if any, which Sellers and Purchasers have instructed the escrow agent to disburse funds from the Indemnification Escrow Fund but which have not actually been disbursed as of such date and, (B) the amount of any claim submitted by any Purchaser Indemnitee prior to such date, in accordance with this Article VIII that remains pending as of such date; and
(c) on the 90th day after the seventh anniversary of the Closing Date, Purchasers and Sellers shall jointly instruct the escrow agent to disburse from the Escrow Fund to each Seller its respective share of the then-remaining funds in the Indemnification Escrow Fund, with such Indemnification Escrow Fund to be reduced by (A) the amount, if any, which Sellers and Purchasers have instructed the escrow agent to disburse funds from the Indemnification Escrow Fund but which have not actually been disbursed as of such date, and (B) the amount of any claim submitted by any Purchaser Indemnitee prior to such date in accordance with this Article VIII that remains pending as of such date.
Article IX
TAX MATTERS
Section 9.1 Section 338 Election. Purchaser shall retain the right of making an irrevocable election under §338(g) of the Code and the regulations promulgated thereunder in connection with the purchase and sale of the Shares of the Subject Companies hereunder (“Section 338(g) Election”). The terms, conditions and procedures relating to the Section 338(g) Election, if made, shall be in accordance with the following:
71
(a) If Purchasers make a Section 338(g) Election for any or all of the Subject Companies, then Purchasers shall indemnify and hold harmless, and reimburse the Sellers for any incremental Taxes (including any interest, penalties and or other statutory additions to Tax) that may be incurred by the Sellers by reason of the Section 338(g) Election being made which computation shall be based upon the difference between:
(i) the after-Tax proceeds that the Sellers would have realized after payment of all federal, state and local Taxes attributable to their sale of stock of the Company to Purchaser in a transaction in which no Section 338(g) Election had been made; and
(ii) the actual after-Tax proceeds realized after payment of all federal, state and local Taxes attributable to their sale of stock of the Company to Purchaser (taking into account, without limitation, the additional Tax liability resulting from and/or attributable to, the Section 338(g) Election, and including Tax liability resulting from the reimbursement hereunder).
(b) The intent of this Section is to provide the same after-Tax proceeds to Sellers if Purchasers make a Section 338(g) Election with respect to the Subject Companies as would be realized by Sellers if no Section 338(g) Election had been made, and shall be interpreted in accordance with such intent. The adjustment resulting from this Section is generally referred to herein as the “338 Tax Adjustment”.
(c) The Parties agree that the Purchase Price and the liabilities of the Subject Companies (plus other relevant items) will be allocated to the assets of the Subject Companies for all purposes (including Tax and financial accounting purposes) in a manner consistent with Code §338 and §1060 and the regulations there under. Purchasers and the Subject Companies shall file all Tax Returns (including amended returns and claims for refund) and information reports in a manner consistent with such allocation.
(d)Sellers shall provide Purchasers with a schedule computing the amount of the Tax resulting from the §338 election within 20 days after the Parties agree to the allocation of the Purchase Price. In making such calculation, the highest corporate federal and state tax rates to which Seller is subject shall be used and any other items of income, deduction, gain, loss, or credits of Sellers shall be ignored.
(e)Purchasers shall pay and/or reimburse the Sellers for all reasonable professional and other fees and costs (including attorneys’, accountants and filing and similar fees) incurred by the Sellers by reason of or in any way relating to the Section 338 Election being made (collectively, the “338 Costs”). Within thirty (30) days of Seller’s Representative providing with an itemization of the 338 Costs, Primary Purchaser shall pay to the Sellers the amount of the 338 Costs.
72
Section 9.2 Tax Returns Due After the Closing Date.
(a) Full Year 2012 and Short Period 2013 Income Tax Returns. With respect to Tax Returns for the Subject Companies for all periods ending on or prior to the Closing Date which are due to be filed after the Closing Date, including the Subject Companies’ U.S. federal and state income and franchise Tax Returns, the Mexican Income Tax return and the Canadian Income Tax Return for the 2012 accounting year (if not filed before the Closing Date) and applicable U.S. federal and state income and franchise Tax Returns and Canadian Income Tax Return for the period from January 1, 2013 to the Closing Date (the “Short Period” with the federal and any related state income and franchise Tax Returns for the Short Period being collectively referred to as the “Short Period Return”), the Company shall engage an outside accounting firm to be selected by the Primary Seller which firm shall prepare the Tax Returns of the Subject Companies (at the Company’s expense) in a manner consistent with prior period practices and under the overall direction and control of the Primary Seller. At least forty-five (45) days prior to filing such Tax Returns (but in the case of the Short Period Returns no later than December 15, 2013), Primary Seller or said accounting firm shall provide copies of such Tax Returns and complete access to all information relied upon as support for such Tax Returns, including to transfer pricing documentation, to Primary Purchaser for its review. Primary Purchaser shall advise Primary Seller of any disagreement with items shown on such Tax Returns within twenty (20) business days after Primary Purchaser’s receipt of such copies. If Primary Purchaser advises Primary Seller of its disagreement with any items on such Tax Returns, Primary Purchaser and Primary Seller shall cooperate to resolve any such disagreement. If Primary Purchaser and Primary Seller are unable to resolve any such disagreement by the due date of such Tax Returns, the disputed Tax Returns will be filed, as prepared, with the appropriate Tax Authority on or before the due date and such disagreement shall be referred to a nationally recognized independent accounting firm chosen by and mutually acceptable to both Primary Purchaser and Primary Seller, which firm shall decide the matter within thirty (30) days after it is submitted to them. The fees of such accounting firm shall be paid by the Company. The decision of such accounting firm shall be final and binding upon the Parties absent fraud or gross negligence. In the event the decision of such accounting firm includes filing an amended Tax Return, the Sellers shall be responsible for filing all amended Tax Returns and Sellers shall be responsible for the payment, if any, of any additional Tax (including penalties and interest thereon) due and payable pursuant to such amended Tax Return, and Sellers shall be entitled to any overpayment of Tax pursuant to such amended Tax Return. Once prepared, Primary Purchaser shall have an appropriate officer of the applicable Subject Company sign such Tax Returns prepared pursuant to this Section 9.2 and shall cause the applicable Subject Company to timely file such Tax Returns. Purchasers shall not be responsible for the completeness and accuracy of any Tax Returns filed pursuant to this Section 9.2. With respect to any Tax covered by this Section 9.2 Sellers shall promptly pay to Purchasers (or be paid by Purchasers, if a credit) the difference between what was accrued
73
as a liability for said Tax in the calculation of the Closing Working Capital and the actual liability shown on the Tax Returns as filed.
(b) Straddle Period Taxes. In the case of any taxable period that includes (but does not end on) the Closing Date (a “Straddle Period”):
(i)Property Taxes. Sellers shall be responsible for all real, personal and intangible property Taxes (“Property Taxes”) allocated to the period on and prior to the Closing Date, regardless of when such Property Taxes become due and payable. Property Taxes allocated to the period on and prior to the Closing Date shall be equal to the amount of such Property Taxes for the entire taxable period multiplied by a fraction, the numerator of which is the number of days that are in the taxable period on and prior to the Closing Date and the denominator of which is the total number of days in the taxable period. The Tax liability for any Property Taxes allocated to periods on and prior to the Closing Date (but payable after the Closing Date) shall be paid by Sellers to Purchasers on the Closing Date.
(ii)2013 Mexican Income Tax Return. Sellers shall be responsible for Mexican income Tax allocated to the Straddle Period. The portion of the Mexican income Tax allocated to the Straddle Period shall be equal to the amount of the entire 2013 Mexican income Tax liability multiplied by a fraction, the numerator of which is the number of days during the Straddle Period that are in the period on and prior to the Closing Date and the denominator of which is the number of days in the Straddle Period. Sellers shall promptly pay to Purchasers (or be credited by Purchasers) the difference between what was accrued as a liability for 2013 Mexican income Taxes in calculating the Closing Working Capital and Sellers’ allocated responsibility as calculated in this Section 9.2(b).
Primary Purchaser shall prepare (at Primary Purchaser’s expense) the 2013 Mexican Income Tax Return. At least thirty (30) days prior to filing such Tax Return, Primary Purchaser shall provide a copy of such Tax Return and complete access to all information relied upon as support for such Tax Return, including transfer pricing documentation, to Primary Seller for its review. Primary Seller shall advise Purchaser of any disagreement with items shown on such Tax Return within fifteen (15) business days after Primary Seller’s receipt of such copy. If Primary Seller advises Primary Purchaser of its disagreement with any items on such Tax Return, Primary Purchaser and Primary Seller shall cooperate to resolve any such disagreement. If Primary Purchaser and Primary Seller are unable to resolve any such disagreement by the due date of such Tax Return, the disputed Tax Return will be filed, as prepared, with the appropriate Tax Authority on or before the due date and such disagreement shall be referred to a firm recognized by the Instituto Mexicano de Contadores Públicos, A.C. chosen by and mutually acceptable to both Primary Purchaser and Primary
74
Seller, which firm shall decide the matter within thirty (30) days after it is submitted to them. The fees of such accounting firm shall be divided equally between the Purchasers and Sellers. The decision of such accounting firm shall be final and binding upon all Parties absent fraud or gross negligence.
(c) Audit - Sales and Use Taxes. In the event that an audit relating to sales and use Taxes of a Subject Company includes both pre‑Closing and post‑Closing periods, Primary Seller and Primary Purchaser will use their respective commercially reasonable efforts to direct the tax auditor to calculate any pre‑Closing assessment based exclusively on pre‑Closing transactions and/or statistical samples and any post‑Closing assessment based exclusively on post‑Closing transactions and/or statistical samples. Notwithstanding Primary Seller’s and Primary Purchaser’s efforts pursuant to the preceding sentence, Sellers shall be liable for any assessment, Liability or other amounts determined to be due with respect to periods or transactions on or prior to the Closing Date and Purchasers shall be liable for any assessment, Liability or other amounts determined to be due with respect to periods or transactions following the Closing Date.
Section 9.3 Tax Refunds. Sellers shall be entitled to any refund of any Taxes of any of the Subject Companies which relate to Tax periods or portions thereof ending on or before the Closing Date to the extent that such refunds where not reflected in the calculation of the Closing Working Capital. Purchasers shall pay to Sellers any such refund (net of any Taxes of any Purchasers or any Subject Company) within fifteen (15) days after the receipt thereof. Notwithstanding anything to the contrary herein, Purchasers shall have no obligation to reimburse Sellers for any Tax attributes, net operating losses or the like.
Section 9.4 Cooperation on Tax Matters.
(a) The Purchasers, the Subject Companies and Sellers shall cooperate fully, as and to the extent reasonably requested by the other Party, in connection with the filing of Tax Returns pursuant to Section 9.2 and any audit, litigation or other proceeding with respect to Taxes. Such cooperation shall include the retention and (upon the other Party’s request) the provision of records and information that are reasonably relevant to any such audit, litigation or other proceeding and making employees available on a mutually convenient basis to provide additional information and explanation of any material provided hereunder. Purchasers and Sellers each shall cause the Subject Companies: (i) to retain all books and records with respect to Tax matters pertinent to the Subject Companies and their subsidiaries relating to any taxable period beginning before the Closing Date until the expiration of the applicable statute of limitations (and, to the extent notified by Purchaser or Sellers, any extensions thereof) of the respective taxable periods, and to abide by all record retention agreements entered into with any taxing authority, and (ii) to give Purchasers and Sellers reasonable written notice prior to transferring, destroying or discarding any such
75
books and records and, to the extent requested by Purchasers or Sellers, as the case may be, to allow any such requesting party to take possession of such books and records.
(b) Purchasers and Sellers further agree, upon request, to use their best efforts to obtain any certificate or other document from any Governmental Entity or any other Person as may be necessary to mitigate, reduce or eliminate any Tax that could be imposed (including, but not limited to, with respect to the transactions contemplated hereby).
Purchasers and Sellers further agree, upon reasonable written request, to provide the other Party with all information that either Party may be required to report pursuant to any applicable Tax laws, including pursuant to §6043 or §6043A of the Code or any regulations promulgated thereunder.
Section 9.5 Amended Returns and Retroactive Elections. Purchasers shall not, and shall not cause or permit the Subject Companies or any of their Subsidiaries to (i) amend any Tax Returns filed with respect to any tax year ending on or before the Closing Date or with respect to any Straddle Period; or (ii) make any Tax election that has retroactive effect to any such year or to any Straddle Period, in each such case without the prior written consent of the Sellers, which consent shall not be unreasonably withheld.
Section 9.6 Certain Transfer Taxes and Fees. All ministerial transfer, documentary, sales, use, registration or other Taxes and all conveyance fees, recording charges, other fees and charges (including penalties and interest) incurred in connection with the consummation of the transactions set forth herein shall be borne by the Purchasers; provided, however, that this Section 9.6 shall not apply to income Taxes, withholding Taxes or other similar Taxes.
Article X
MISCELLANEOUS
Section 10.1 Fees and Expenses. Except as set forth herein, all costs and expenses incurred in connection with this Agreement and the consummation of the transactions contemplated hereby shall be paid by the Party incurring such costs and expenses.
Section 10.2 Extension; Waiver. Subject to the express limitations herein and subject to applicable Law, at any time prior to the Closing, the Parties, may (i) extend the time for the performance of any of the obligations or other acts of the other Party hereto, or the End Date; (ii) waive any inaccuracies in the representations and warranties contained herein by the other Party or in any document, certificate or writing delivered pursuant hereto by such other Party; or (iii) waive compliance with any of the agreements or conditions contained herein. Any agreement on the part of any Party to any such extension or waiver shall be valid only if set forth in an instrument in writing signed by or on behalf of both
76
Parties or such Party, as the case may be. No failure or delay on the part of any Party hereto in the exercise of any right hereunder shall impair such right or be construed as a waiver of, or acquiescence in, any breach of any representation, warranty, covenant or agreement herein, nor shall any single or partial exercise of any such right preclude other or further exercise thereof or of any other right.
Section 10.3 Notices.
(a) Except as otherwise provided herein, all notices, requests, claims, demands, waivers and other communications hereunder shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail to Primary Seller in case of any notices, requests, claims, demands, waivers and other communication addressed to any of the Sellers, or to Primary Purchaser in case of notices, requests, claims, demands, waivers and other communications addressed to any of the Purchasers, as follows (or, in each case, as otherwise notified by Primary Seller or Primary Purchaser) and shall be effective and deemed to have been given when received if delivered by hand or overnight courier service or certified or registered mail on any Business Day:
If to Sellers, to Primary Seller:
Blvd. Xxxxxx Xxxxx Xxxxxxx No. 138
Col. Xxxxx xx Xxxxxxxxxxx
00000, Xxxxxx, Distrito Federal
Attention: Xx. Xxxxxx Xxxxx Xxxx
email: xxxxxx@xxxxx.xxx.xx
if to Purchaser, to Primary Purchaser:
The Xxxxxxx-Xxxxxxxx Company
000 Xxxxxxxx Xxxxxx
Xxxxxxxxx, Xxxx 00000
XXX
Attention: Senior Vice President - Corporate Planning and Development
With a copy to:
The Xxxxxxx-Xxxxxxxx Company
000 Xxxxxxxx Xxxxxx
Xxxxxxxxx, Xxxx 00000
XXX
Attention: Senior Vice President, General Counsel and Secretary
77
(b) Notices sent by multiple means, each of which is in compliance with the provisions of this Agreement will be deemed to have been received at the earliest time provided for by this Agreement.
Section 10.4 Entire Agreement. This Agreement, together with the Exhibits, Annexes, Schedules and the Sellers Disclosure Letter, contains the entire understanding of the Parties hereto with respect to the subject matter contained herein and supersedes all prior agreements and understandings, oral and written, with respect thereto.
Section 10.5 Binding Effect; Benefit; Assignment. This Agreement shall inure to the benefit of and be binding upon the Parties. Except with respect to Article VIII of this Agreement, which shall inure to the benefit of each Purchaser Indemnitee and Seller Indemnitee, all of whom are intended as express third-party beneficiaries thereof, no other Person not party to this Agreement shall be entitled to the benefits of this Agreement. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the Parties without the prior written consent of the other Party.
Section 10.6 Amendment and Modification. This Agreement may not be amended except by a written instrument executed by all Parties to this Agreement.
Section 10.7 Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, and all of which together shall be deemed to be one and the same instrument. Signed counterparts of this Agreement may be delivered by facsimile and by scanned .pdf image.
Section 10.8 Applicable Law. THIS AGREEMENT AND THE LEGAL RELATIONS BETWEEN THE PARTIES HERETO SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE UNITED MEXICAN STATES, WITHOUT REGARD TO THE CONFLICT OF LAWS RULES THEREOF.
Section 10.9 Arbitration.
(a) Except with respect to any claim asserted with respect to Sections 5.2, 5.3, 5.4, 5.9, 5.12, 5.13 and 5.16. pursuant to Section 10.11, any dispute, controversy or claim arising out of, relating to or in connection with this Agreement, including any question regarding its existence, validity or termination, or regarding a breach of this Agreement, shall be referred to and settled by arbitration under and in accordance with the Rules of Arbitration of the International Chamber of Commerce (the “ICC Rules”).
(b) The arbitration proceeding will take place in Dallas, Texas, U.S., and will be conducted in the English language. The arbitration panel will consist of three (3) arbitrators appointed pursuant to the ICC Rules; provided, however, that the Primary Parties
78
shall have thirty (30) days from the confirmation of the second arbitrator to agree upon the third arbitrator who shall act as president. Failing such agreement, the third arbitrator shall be appointed by the International Chamber of Commerce.
Section 10.10 Severability. If any term, provision, covenant or restriction contained in this Agreement is held by a court of competent jurisdiction or other authority to be invalid, void, unenforceable or against its regulatory policy, the remainder of the terms, provisions, covenants and restrictions contained in this Agreement shall remain valid and binding and shall in no way be affected, impaired or invalidated, and this Agreement shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable term, provision, covenant or restriction or any portion thereof had never been contained herein.
Section 10.11 Specific Enforcement. The Parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement to be performed after the Closing Date were not performed in accordance with their specific terms or were otherwise breached or threatened to be breached and that an award of money damages would be inadequate in such event. Accordingly, it is acknowledged that the Parties shall be entitled to request an Order for specific performance to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement, in addition to any other remedy to which they are entitled at law as a remedy for any such breach or threatened breach. Each Party further agrees that neither the other Party nor any other Person shall be required to obtain, furnish or post any bond or similar instrument in connection with or as a condition to obtaining any remedy referred to in this Section 10.11, and each Party hereto irrevocably waives any right it may have to require the obtaining, furnishing or posting of any such bond or similar instrument.
Section 10.12 Rules of Construction. The Parties hereto agree that they have been represented by counsel during the negotiation and execution of this Agreement and have participated jointly in the drafting of this Agreement and, therefore, waive the application of any Law, holding or rule of construction providing that ambiguities in an agreement or other document will be construed against the Party drafting such agreement or document.
[Remainder of page intentionally left blank]
79
IN WITNESS WHEREOF, Sellers and Purchasers execute this Agreement as of the date first above written.
SELLERS
AVISEP, S.A. DE C.V.
By: /s/ Xxxxxx Xxxxx Xxxx
Title: Attorney-in-fact
BEVISEP, S.A. DE C.V.
By: /s/ Xxxxx Xxxxx Xxxxxxxxx
Title: Attorney-in-fact
PURCHASERS
The Xxxxxxx-Xxxxxxxx Company
By: /s/ Xxxx X. Xxxxxxxx
Name: Xxxx X. Xxxxxxxx
Title: Senior Vice President - Finance and Chief Financial Officer
Xxxxxxx-Xxxxxxxx (Caribbean) N.V.
By: /s/ Xxxx X. Xxxxxxxx
Name: Xxxx X. Xxxxxxxx
Title: Senior Vice President - Finance and Chief Financial Officer